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ABSTRACT

TOWARDS EARLY STAGE DISEASE DETECTION IN MICRODEVICES:
FABRICATION AND TESTING OF MICRO TOTAL ANALYSIS SYSTEMS FOR
BIOANALYTICAL APPLICATIONS

Tao Pan
Department of Chemistry and Biochemistry
Doctor of Philosophy
The past few years have seen a rapid expansion in interest in the characterization of the
entire complement of proteins, or proteome. Micro total analysis systems (μTAS) are an
emerging promising method, offering rapid, sensitive and low sample consumption
separations.
I have demonstrated microchip capillary electrophoresis (CE) devices made of CaF2.
New methods have been developed for micromachining enclosed capillaries in CaF2. CE
analysis of fluorescently labeled amino acids was used to illustrate bioanalytical
applications of these microdevices. Initial on-chip infrared spectroscopy results for
qualitative analyte identification were achieved in microfluidic CaF2 channels.
I have also shown the evaluation of poly(methylmethacrylate) (PMMA) and thermoset
polyester (TPE) microchips for use in protein profiling. To improve separation efficiency
and reduce protein adsorption, dynamic coating and poly(ethylene glycol) (PEG) grafting
using atom transfer radical polymerization (ATRP) have been used in PMMA

microdevices.

Proteins,

peptides

and

protein

digests

have

been

separated

electrophoretically in these PMMA microchips. My results demonstrate that PMMA
microdevices should be well suited as microfluidic systems for high performance
separations of complex biological mixtures.
In-channel ATRP has been developed for the surface modification of TPE microdevices.
Characterization indicates that PEG-modified microchannels have much lower and more
pH-stable electroosmotic flow, more hydrophilic surfaces and reduced nonspecific
protein adsorption. CE of amino acid and peptide mixtures in these PEG-modified TPE
microchips had good reproducibility. Phosducin-like protein and phosphorylated
phosducin-like protein were also separated to measure the phosphorylation efficiency.
My results show that PEG-grafted TPE microchips have broad potential application in
biomolecular analysis.
Cancer marker analysis is important for medical research and applications. I report a
method that can covalently attach appropriately oriented antibodies of interest on
monolith surfaces. To reduce nonspecific adsorption, protein solutions were used to
effectively block the monolith surface. Selective preconcentration and elution of human
chorionic gonadotropin have been performed in my affinity columns, demonstrating that
this type of system should have promising applications in cancer marker detection.
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Chapter 1. Introduction
1.1 Micro Total Analysis Systems for Bioanalytical Applications
1.1.1 Introduction to Micro Total Analysis Systems
Micro total analysis systems (μTAS), or miniaturized analysis platforms, have greatly
expanded in recent years. In the 1970s, the first μTAS device, a gas chromatography
analyzer, was fabricated on a silicon wafer to separate a simple mixture in seconds [1, 2].
Although this device was remarkable, μTAS did not get much attention until the early
1990s when several articles about miniaturized analysis systems fabricated in inorganic
materials were published [3-5]. Since then, μTAS have grown rapidly, and today it is one
of the hottest research areas in analytical chemistry. Many types of materials (both
inorganic and polymeric) have been evaluated as μTAS device substrates; moreover,
various methods have been developed for device production, surface modification and
integration. Also, many separation methods have been miniaturized into μTAS.
Compared to conventional analysis systems, μTAS have several advantages. First, the
cycle time for μTAS analysis is shorter; second, sample consumption is lower. Third,
multiple functions such as sample pretreatment, separation, and detection can be
integrated into one μTAS device [6, 7]. Fourth, μTAS can give comparable performance
to conventional analysis methods. Last, high-throughput analysis can be achieved by
integration of parallel μTAS units on one chip [8].
Nowadays, the most common application for μTAS is microchip capillary electrophoresis
(CE), because of two distinct advantages that fit the requirements of miniaturization. The
first is that the electroosmotic flow (EOF) in CE can serve as a pumping system. Thus, the

1

transportation and injection of analytes in CE can be controlled easily by adjusting
electrical potentials, so external valves or pumps are not needed. The second advantage is
that in CE, band broadening is caused only by longitudinal diffusion, which makes the
separation efficiency in microchip CE exclusively dependent on the magnitude of the
voltage used. Thus, in a microchip with a very short separation capillary, high efficiency
can still be achieved.
1.1.2 Microfluidic Devices Made of Inorganic Materials
1.1.2.1 Inorganic Materials
Due to rapid developments in the semiconductor industry, photolithography and
fabrication of glass, quartz and silicon have been investigated intensively. Meanwhile,
advances in separation science indicate that miniaturization is an effective way to improve
separation performance, and reduce separation time and sample consumption [9]. All
these factors make fabrication of inorganic material microfluidic devices both possible
and desirable.
Inorganic substrates were the first-generation materials used in making μTAS platforms.
The first microfluidic devices were made in silicon [2] and glass [3, 4]. Nowadays, a
broad range of inorganic materials are used in μTAS, including glass [3, 4, 10, 11], silicon
[2, 12, 13], quartz [14-16] and CaF2 [17]. Among all these materials, glass is the most
widely used, because it has good mechanical, electrical, optical and thermal properties. In
addition, the surface chemistry of glass is well developed. The second most commonly
used inorganic material is silicon. However, silicon is not transparent to UV or visible
light, and its breakdown voltage is relatively low (~500 V) [18]. Thus, only microdevices
that can function within these constraints are made completely in silicon. Since silicon has
2

good mechanical and thermal properties, silicon-glass (or silicon-quartz) hybrid
microfluidic devices are found often [19, 20]. Quartz, or fused silica, has superior
physical and optical properties to glass or silicon, and is a highly suitable material for
microfluidic devices. However, the high cost and difficult fabrication of quartz limit its
application to special circumstances (e.g., when UV detection is required). CaF2 is the
inorganic materials, CaF2 has the best optical properties [17], and it is transparent to a
wide range of wavelengths of light (170 – 7800 nm). Thus, CaF2 microfluidic devices are
suitable for various types of optical detection methods, including IR, UV, Raman,
fluorescence, etc. However, the fabrication and bonding procedures are a limitation in
making microdevices from CaF2.
1.1.2.2 Fabrication of Glass, Quartz and Silicon Microfluidic Devices
The fabrication of glass, quartz and silicon microfluidic devices is based on
photolithography techniques. Photoresist, a light-sensitive material/polymer, is key to this
process. In photolithography, photoresist is used to form patterned features on surfaces.
The fabrication process includes pretreatment, photolithography, etching and bonding. In
a typical fabrication process, a substrate is cleaned by hot, concentrated H2SO4/H2O2, or
NH4F/HF (Figure 1.1a). Then, an etch mask (e.g., Cr/Au [10, 14], amorphous Si [8] or
SiO2 [21, 22]) is coated on the substrate (Figure 1.1b). The coating protects the inorganic
substrate during the etching process. Next, the substrate is attached to a spinner, and
several drops of photoresist are put on top of the substrate. Once the assembly is spinning,
a thin layer of photoresist will be coated on top of the etch mask (Figure 1.1c) [4, 8, 23].
After soft baking, a photomask, which is a glass plate or a transparent polymer sheet
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bearing high-resolution patterns, is positioned on the top of the surface. The substrate is
exposed to UV radiation through the photomask for a short period of time, which
transfers the pattern on the photomask to the photoresist (Figure 1.1d). During
development, some parts of the photoresist will be removed, leaving a pattern on the
substrate.
There are two types of photoresist: positive and negative [24]. When positive photoresist
is used, only the UV-exposed material will be dissolved during development; the
unexposed photoresist will remain on the substrate (Figure 1.1e). Thus, the pattern
transferred to the photoresist is identical to the photomask. In contrast, when a negative
photoresist is used, the unexposed photoresist will be removed, while the UV-exposed
photoresist will stay. Thus, a reversed pattern is generated after development (Figure 1.1i).
After photoresist development, patterned inorganic substrates are typically etched to
create microstructures (Figure 1.1f, g, j, k). For silicon etching in the liquid phase,
concentrated KOH or HNA solution (a mixture of HF, HNO3 and CH3COOH) is used
commonly [21, 22, 25]. KOH solution is a typical anisotropic etchant for silicon,
attacking the <100> plane and resulting in the side wall forming a 54.74º angle with the
top surface [24]. HNA solution is an isotropic etchant, which produces rounded sidewalls
and corners on silicon surfaces. In the gas phase, reactive ion etching (RIE) has also been
applied to silicon and can produce high-aspect-ratio and complex patterns [26]. For glass
and quartz, HF-containing etchants can be used, including HF/HNO3, HF/NH4F, HF/HCl
and concentrated HF [10, 11, 14, 27]. To produce high-aspect-ratio features on glass and
quartz surfaces, RIE has also been used [15]. Last, the photoresist and/or etch mask need
to be removed to give the final patterned substrate (Figure 1.1h, l).
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Figure 1.1 Fabrication of inorganic microfluidic systems.
1.1.2.3. Bonding Techniques
Thermal bonding is the dominant method for glass, silicon and quartz microchannel
enclosure. Typically, clean glass substrates are treated by hot, concentrated H2SO4/H2O2,
generating reactive silanol groups. Then the glass substrates are clamped together to form
a temporary bond. To obtain permanent bonding, the assembly is heated in an oven at a
high temperature for a period of time, until siloxane bonds are formed between silanol
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groups at the contact surface. Most glass bonding is performed in the temperature range
of 500 – 700 ºC [10, 11, 23]. Sometimes, temperature programming is necessary for
optimal bonding. For the sealing of quartz substrates, a very high temperature (~1100 ºC)
is needed. For the bonding of silicon to silicon or glass, electric-field-assisted thermal
bonding (or anodic bonding) is used, with a potential ranging from 200 – 1000 V applied
at 180 – 500 ºC to assist the thermal bonding process [13, 28, 29].
Adhesive bonding is an alternative method for enclosing inorganic microfluidic devices
[17, 30, 31]. One advantage of adhesive bonding is that it can be applied to almost all
kinds of materials. Moreover, the bonding process can be carried out at lower
temperatures (even at room temperature). However, a major concern for adhesive bonding
is that the adhesive can affect the surface properties of the microchannels, which may
influence device performance. In CaF2 substrate bonding, a patterned photoresist layer is
prepared on a cover plate, which is carefully aligned with a patterned CaF2 substrate to
form a bonding assembly. Then, this assembly is heated to 120 ºC for 30 min to achieve
bonding [17]. In this approach, the patterned photoresist serves as an adhesive. Since the
channel section in the bonded CaF2 device is free of photoresist, the influence of the
adhesive on the channel surface properties can be minimized.
1.1.2.4 Thin–Film Fabrication
Recently, a new approach called thin-film fabrication was reported [32], as shown in
Figure 1.2. First, a quartz (or other) substrate is cleaned, a ∼500 nm thick layer of
aluminum is deposited by thermal evaporation, and a ∼3 μm thick layer of photoresist is
spin coated afterwards (Figure 1.2a). The aluminum and photoresist form a sacrificial
layer for microfabrication. Photolithography techniques are used to pattern the sacrificial
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layer, followed by removal of exposed photoresist and aluminum from unpatterned areas
(Figure 1.2b). The channel features are thus defined by the sacrificial layer, and a SiO2
layer is deposited on the substrate to form channels and enclose the sacrificial features
(Figure 1.2c). Last, the sacrificial layer is removed to form a hollow tube structure (Figure
1.2d).
Thin-film methods have several advantages over conventional fabrication approaches for
microdevices. First, one can build channels and structures on almost any kind of material.
Also, by changing the films which are deposited on the substrate, channel patterns can be
made out of different materials. Moreover, using this technique, complex (e.g., threedimensional) structures can be fabricated easily on surfaces, because features are created
from bottom to top. Thus, after one layer of thin-film feature is fabricated, a new structure
can be added on top. Depending on the structure and geometry of the sacrificial layers,
unique fluidic designs can be created easily. Furthermore, because the SiO2 layer
deposited on the substrate is transparent to a wide range of light wavelengths, it is
possible to detect in the visible and UV. Finally, this technique enables multiple
microdevices to be fabricated on one substrate simultaneously, making parallel analysis
possible. However, the major challenge with thin-film methods is removal of the
sacrificial layer.
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Top PECVD SiO2 layer

Figure 1.2 Fabrication of microfluidic devices using thin-film methods. (a) A quartz
substrate is coated with aluminum and photoresist. (b) The photoresist and
aluminum are patterned. (c) Plasma enhanced chemical vapor depostion (PECVD) is
used to deposit SiO2 over the sacrificial layer. (d) Etching of the sacrificial layer
forms a hollow tube.
1.1.3 Microfluidics Made in Polymeric Materials
1.1.3.1 Polymer Materials
Although microfluidic devices made using inorganic materials have had great success, the
disadvantages of inorganic substrates (such as cost, fragility, and fabrication) have limited
their application. Thus, scientists have been investigating the possibility of fabricating
microfluidic devices in polymeric materials. Nowadays, many commericial polymers
have been used in microfluidic device fabrication. The most commonly used polymers are
polydimethylsiloxane (PDMS) [33-35], poly(methyl methacrylate) (PMMA) [21, 22, 36,
37], polystyrene (PS) [38, 39], polycarbonate (PC) [40, 41], polyimide (PI) [42, 43] and
cyclic olefin copolymer (COC) [44-46].

Due to the diverse properties of different

polymeric materials, various methods have been developed for the fabrication of polymer
microfluidic devices.
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1.1.3.2 Forming Features in Polymer Surfaces
Imprinting. Imprinting is probably the most widely used method for polymer
microdevice fabrication [21, 22, 45, 47]. Polymers that can be imprinted include PMMA,
PC, PS, polyethylene terephthalate (PET), COC and many others. To use this method, one
needs a hard, patterned template (made of silicon, glass, metal or SU-8 photoresist) and a
softened polymer substrate. When the hard template and softened polymer are clamped
together, the pattern on the template is transferred to the polymer.
Two methods have been developed for imprinting: hot embossing and solvent imprinting.
Typically, hot embossing is accomplished in several steps. First, a polymer substrate is
clamped to a template (Figure 1.3a) and placed in an oven at a temperature higher than
the glass transition temperature (Tg) of the polymer. After sufficient time, the polymer
substrate is softened and pressure is applied to compress the polymer against the template,
which embosses the patterns on the template into the polymer surface (Figure 1.3b). Then,
the assembly is cooled to room temperature, and the patterned polymer substrate is
detached from the template (Figure 1.3c). Trapping of air bubbles and thermally induced
stress are the two major concerns for hot embossing [48]. To obtain optimal results, the
template and polymer substrates need to be cleaned (e.g., in a cleanroom). Alternatively,
hot embossing under vacuum is another choice for good imprinting results [49].
Recently, a new method called solvent imprinting was developed (Fig. 1.3d-f). First,
several drops of a solvent (e.g., acetonitrile for PMMA) are deposited on a polymer
surface, and then a planar template (with patterned SU-8 photoresist) is compressed
against the polymer substrate (Figure 1.3d) until the pattern is transferred from the
template to the softened polymer surface (Figure 1.3e). Then, the substrate is detached
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from the template, and the imprinted polymer piece is ready to use (Figure 1.3f).
Compared to hot embossing, solvent imprinting has several advantages. First, solvent
imprinting is done at room temperature; second, the cycle time for solvent imprinting is
much shorter than hot embossing; and last, the solvent imprinting method can be coupled
directly with solvent bonding.

a

Template

d

Substrate

b

e

c

f

Template
Solvent
Substrate

Figure 1.3 Schematics of imprinting methods. (a-c) Hot embossing; (d-f) solvent
imprinting.
Silicon and glass templates can be broken during imprinting, due to uneven pressure or
thermally induced stress. Thus, metal templates are sometimes utilized to improve
imprinting results [50]. However, glass or silicon templates can still be used to imprint 50
to 100 polymeric substrates.
Injection Molding. Injection molding is another method that is used commonly for
microfluidic device fabrication [51]. The procedure for injection molding is as follows.
First, an assembly with an evacuated cartridge (having templates inside) is prepared. Then,
a melted polymer is injected into the cartridge under high pressure to form a replica. After
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cooling, the replica can be removed from the cartridge, which is then ready for another
run of injection molding.
Compared to imprinting, injection molding is easier for mass production. In addition, the
cycle time for injection molding is shorter than for imprinting methods. Moreover, the
reproducibility of injection molding is high, as long as the temperature and pressure are
controlled appropriately. Lastly, attachments such as optical fibers or metal wires can be
integrated easily into the final molded microfluidic devices. The main concern for
injection molding is the high cost of the instrumentation, including metal templates [52].
Casting. Casting, or soft lithography, is also a commonly used method for microfluidic
device fabrication [53]. Compared to imprinting and injection molding, casting is simpler
and easier to control. Thanks to developments in elastomeric polymers, casting can be
done on many kinds of materials. Moreover, complex 3D structures (including valves,
pumps, etc.) can be fabricated readily using casting [54-57].
PDMS (silicone rubber) is the most widely used elastomer in casting. PDMS monomer is
a liquid at room temperature, but it readily solidifies when mixed with a cross-linking
agent. For a typical casting process, liquid PDMS is mixed with cross-linking agent and
poured into a cartridge with a template on the bottom. Then, the PDMS liquid is cured at
room temperature or at high temperature (to reduce curing time), during which the pattern
on the template is transferred to the PDMS surface. The casting process is done under
mild conditions. Metal, glass, silicon, and softer materials such as SU-8 or even PDMS
can serve as templates.
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Besides PDMS, many other polymer materials can be used in casting. For example,
casting of microdevices from photocurable perfluoropolyethers [58], thermoset polyester
[59, 60] and poly(ethylene glycol) (PEG) [61] has been accomplished.
Laser Ablation.

Laser ablation or laser micromachining is a direct (template-free)

method for microfluidic device fabrication. The features on a polymer surface are
produced by laser machining. Typically, in laser ablation the substrate is first positioned
on a computer-controlled X-Y motorized stage, and a laser is focused on the surface. The
laser will machine material photochemically or by thermal effects. Complex patterns can
be fabricated by moving the motorized stage, which is normally controlled by a computeraided design program.
Two types of laser systems (UV and IR) are used in ablation. UV excimer lasers such as
ArF (193 nm) or KrF (248 nm) [62, 63] are operated using pulses of nanosecond duration,
machining substrates photochemically without generating much heat. They can make
features smaller than 100 μm, and the channel walls are normally straight. CO2 lasers [36,
64] operate in the IR, so they deform polymer microstructures through photothermal
effects. Thus, cross sections of channels made by CO2 lasers have a Gaussian-like shape,
and features are normally larger than 150 μm.
Laser ablation can be applied to many kinds of commercial polymers. One advantage of
laser ablation is that it does not need a photomask or template, which makes it very easy
to change device design. Moreover, since UV excimer lasers work photochemically, it is
possible to carry out surface modification during the laser ablation process.
However, features made by laser ablation are normally rougher than ones made by
imprinting, injection molding, or casting. Also, side products produced during laser
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ablation may be deposited or trapped on the polymer surfaces, which may affect substrate
properties.
Microfluidic Tectonics.

Microfluidic tectonics is a novel fabrication approach for

microfluidic systems, particularly for complex structures [65, 66]. In a typical
microfluidic tectonics process, the first step is to prepare a cartridge with fluidic
connections and posts. Then, a monomer solution containing photoinitiators is filled in the
cartridge chamber (Figure 1.4a). The size of the cartridge will define the dimensions of
the fabricated microdevices. A photomask is positioned on the cartridge, and UV
radiation (usually 300 – 400 nm) is used to polymerize the monomer solution (Figure 1.4b)
in areas not blocked by the pattern, whereas the monomer solution shadowed by the
photomask remains unreacted (Figure 1.4c). Last, the unreacted monomer solution is
flushed away to form the final microfluidic structures (Figure 1.4d).
One unique feature of microfluidic tectonics is that it does not need a template or a
bonding process. Also, microstructures can be fabricated in parallel in a short period of
time. In addition, by using different photomasks, monomers, and multi-step UV
polymerization, complex 3D microstructures such as sensors, valves and pumps can be
fabricated. Moreover, membranes and metal wires can be integrated into microfluidic
devices with this technique [67].
However, microfluidic tectonics cannot be used to fabricate features smaller than ~100
μm, because of side reactions of the UV-initiated polymerization. During patterning, light
diffraction at the edge of the photomask may cause partial polymerization in regions close
to the pattern edge. Moreover, diffusion of free radicals may also induce polymerization
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in undesired locations. To obtain good results using this technique, monomers with low
shrinkage and fast reaction should be used.

Photomask

a

b

Polymer

Unpolymerized
monomer

Channels

c

d

Figure 1.4 Microfluidic tectonics process.
SU-8 Photolithography. Recently, negative SU-8 photoresists have been applied in
polymeric microdevice fabrication [68, 69]. Because SU-8 has high thermal stability,
chemical resistance, and mechanical strength, it is suitable for microdevice fabrication.
The fabrication of SU-8 microdevices is carried out as follows. First, a thin film of SU-8
is spin coated on a glass wafer. This coated SU-8 is exposed to UV radiation through a
photomask. Then, a new layer of SU-8 is spin coated on the first SU-8 layer, and is also

14

exposed to UV radiation through a patterning mask. After exposure, the SU-8 covered by
the photomask will be removed in a developer solution, which creates the pattern. The
depth of the microstructure is defined by the thickness of the second SU-8 layer. The
pattern can then be enclosed by attaching a glass wafer with a SU-8 layer, performing UV
exposure and baking at high-temperature to bond the layers together. Because of its good
mechanical strength, SU-8 can be used to make features that have a depth of up to 50 μm.
In addition, complex 3D structures can be made readily using SU-8, and bonding is
straightforward. However, a concern with this technique is that EOF in SU-8
microchannels is highly pH-dependent [68].
1.1.3.3 Bonding Techniques
Thermal Bonding. Thermal bonding is used widely for enclosing polymeric
microdevices [21, 70-72]. Typically, a patterned substrate and cover plate are clamped
together and heated to near the Tg of the polymer. During this period, intermolecular
interaction occurs at the contact surfaces between the two polymer substrates. After an
appropriate time, the temperature is lowered, and the bonded microdevice is released from
the clamp.
Although thermal bonding is simple and used widely, it still has some disadvantages. The
most important problem is that the bonding is not very strong, so delamination often
occurs. Also, because the bonding temperature is close to the Tg of the polymer, channel
deformation sometimes happens. Thus, to achieve optimal thermal bonding, one needs to
adjust carefully the temperature, pressure, and time.
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Solvent Bonding. Unlike thermal bonding, solvent bonding has only been applied to
polymer microfluidic devices more recently [22, 26, 70]. Two approaches have been used
for solvent bonding, as shown in Figure 1.5. In the first method, a thin layer of organic
solvent is spin coated on the cover plate (Figure 1.5a) Immediately after this step, a
patterned plate is compressed against the coated piece (Figure 1.5b). The pressure is kept
for a sufficient time until the organic solvent partially dissolves the two polymer surfaces
and strong intermolecular interactions bond them together (Figure 1.5c) [70]. In the
second approach, a sacrificial layer (e.g., paraffin wax) is used. In a typical sacrificial
layer solvent bonding process, the first step is to cover the patterned polymeric substrate
with a PDMS slab to form an enclosed assembly (Figure 1.5d). This assembly is heated
above the melting point of the wax, and vacuum is used to fill the channels with melted
wax. After all the channels and reservoirs are filled, the assembly is cooled to room
temperature and the sacrificial layer is solidified (Figure 1.5e). The PDMS slab is
removed carefully from the patterned polymer substrate, and the sacrificial layer protects
the channels during the next step. An organic solvent is dispensed on the polymer surface,
and a cover plate is compressed against the patterned substrate (Figure 1.5f) until solvent
bonding is complete (~2 min). The sacrificial layer can be removed by pipette after
heating the bonded microdevice to melt the wax (Figure 1.5g). Finally, hexane is used to
dissolve any leftover sacrificial material in the channels [22].
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Figure 1.5 Schematic diagram of solvent bonding (a-c) without and (d-g) with a
sacrificial layer.
Compared to thermal bonding methods, solvent bonding can be operated at lower
temperature, and the bonding strength is much higher. However, the channel surface may
be modified by the bonding solvent, which could affect microdevice performance,
although this has not been observed in practice [22].
Adhesive Bonding. Adhesive bonding is a method somewhat similar to solvent bonding
[34, 73], but the bonding adhesive does not dissolve the surface. Instead, it acts as a glue
to secure two polymeric substrates together. To ensure that the surface properties are not
changed, an adhesive with similar characteristics to the substrate should be selected, and a
very thin layer of adhesive is preferred.
Chemical Bonding. Chemical bonding is also called permanent bonding. In this method,
chemical bonds are formed between the contact surfaces of two polymer pieces. Thus, the
bonding strength is high and no delamination is expected. Since polymer materials have
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different chemical properties, specific methods need to be developed for various polymer
types.
Covalent bonding of PDMS to glass, silicon, and PDMS has gained significant interest in
recent years. It is well known that PDMS can adhere to materials through intermolecular
interactions [74-76]. To bond PDMS covalently, one needs to activate both the PDMS
and the other surface by O2 plasma [35, 53]. During plasma treatment, siloxane bonds on
the PDMS surface are activated through cleavage. If the PDMS and blank surface are held
together for several minutes, new chemical bonds will form at the contact interface. The
reactive broken bonds formed through plasma activation last less than 30 s, such that
surfaces must be placed together very quickly [53, 77].
Commercially available PDMS bonding kits employ a different mechanism [57], using
two different types of PDMS. One has vinyl groups and a platinum catalyst, while the
other has a crosslinker and silicon hydride groups. When these two types of PDMS are
brought into contact, the vinyl groups react with silicon hydride to form covalent bonds
between the two PDMS surfaces.
TPE is another successful example of chemical bonding enclosure [59, 60]. In the TPE
monomer solution, a photoinitiator (2,2-dimethoxy-2-phenylacetophenone, DMPA) and a
thermal initiator (methyl ethyl ketone peroxide, MEKP) are used. During the casting
process, only DMPA is used to polymerize the TPE. To enclose TPE microchannels, a
patterned TPE piece is clamped against the TPE cover plate, and the assembly is
subjected to UV radiation. Finally, the assembly is heated, and MEKP initiates the
thermally induced polymerization of the unsaturated polyester backbones in the TPE
substrates to finish the chemical bonding process.
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Resin-Gas Injection Bonding. Resin-gas injection bonding was introduced in 2001 [78,
79]. This method utilizes polymerization of a resin in between two polymer substrates to
bond them together as shown in Figure 1.6. Two PMMA pieces (a patterned and cover
plate)

are

clamped

together,

and

a

monomer

solution

containing

2-

hydroxyethylmethacrylate (HEMA) and DMPA is flushed through one of the reservoirs
(Figure 1.6a). Once the monomer solution fills the channels and gaps between the PMMA
pieces, nitrogen gas or vacuum is used to remove the monomer solution from the channels;
however, in between the PMMA pieces there is still a thin layer of monomer solution
(Figure 1.6b). In the last step, the assembly is exposed to UV light for HEMA
polymerization, during which the two PMMA pieces are bonded by poly(HEMA) (Figure
1.6c).

Figure 1.6 Scheme of resin-gas injection bonding
Resin-gas injection bonding can be applied to many kinds of polymer materials. Besides
HEMA, other resins, such as epoxy and unsaturated polyester, can also be used to bond
polymer substrates [37, 78]. Several methods have been applied to initiate resin curing
(polymerization), including light-initiated polymerization, thermal initiation and redox
initiation [37, 78, 79].
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One unique feature of resin-gas injection is that it can modify the surface during bonding,
thus reducing device fabrication time. However, this method may also contaminate the
channel surface, which could affect device performance.

1.2 Microchip CE
1.2.1 Introduction
Electrophoresis is one of the most commonly used techniques for biological sample
analysis. In electrophoresis, charged analytes migrate under an applied voltage, and they
are separated according to differences in both their net charge and size. CE has been used
widely for the analysis of peptides [80, 81], proteins [81, 82], nucleic acids [23, 83],
saccharides [84], inorganic ions [85] and small organic molecules [86].
CE was used as the separation technique in early μTAS devices [3, 4]. Since then,
microchip CE has become very popular, and is probably the dominant separation method
in μTAS. The most mature application for microchip CE is DNA analysis [23, 87], but
nowadays protein analysis in microchips has gained increased attention [21, 88, 89].
1.2.2 Theory
1.2.2.1 Fundamental Theory
The fundamental theory of modern CE was first described by Jorgenson and Lukacs [90,
91]. CE is a technique that uses an electric field to separate charged analytes. A scheme of
microchip CE is shown in Figure 1.7.
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Figure 1.7 Scheme of a microchip CE instrument.
When an electric field is applied through the separation channel, the charged analytes will
move toward the electrode of opposite polarity. Different analytes will have different
migration velocities (up), which are dependent on the electrophoretic mobility of each
analyte (μp) and the applied electric field (E). The migration velocity can be expressed
according to Equation 1.1.
up = μpE

(1.1)

In CE, a constant electric field is applied, so two analytes must have a different μp to be
separated. The electrophoretic mobility of an analyte at a given pH is given by Equation
1.2.

μ

p

=

z
6πη r

(1.2)
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In this equation, η is the viscosity of the buffer solution, z is the charge and r is the Stokes
radius of the analyte. Equation 1.2 shows that the electrophoretic mobility of an analyte is
proportional to its net charge, and is inversely proportional to its radius. The Stokes radius
is given by Equation 1.3

r=

k BT
6πηD

(1.3)

where kB is the Boltzmann constant, T is the temperature, and D is the diffusion
coefficient.
The above discussion gives the theoretical explanation for electrophoretic mobility.
However, it is not easy to calculate electrophoretic mobility directly from theory. In
practice, the electrophoretic mobility is determined experimentally from the migration
time of an analyte, the applied potential and the column length, as shown in Equation 1.4.

μ

⎛ L ⎞⎛ ⎞
= ⎜ ⎟⎜⎜ Lt ⎟⎟
p
⎜ ⎟ V
⎝ t r ⎠⎝ ⎠

(1.4)

Here, L is the migration distance of an analyte from injection to the detection point, tr is
the migration time of the analyte, V is the applied voltage, and Lt is the total length of the
capillary. Since only charged species are affected by the electric field, neutral analytes are
not separated by CE.
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1.2.2.2 Electroosmotic Flow (EOF)
In Section 1.2.2.1, the fundamental theory of CE is given, based on the assumption that
the electric field and friction are the only forces that exist during CE. In most cases, due
to the surface properties of columns, EOF also occurs during CE. Thus, the effects of
EOF must be included in CE theory. EOF is the movement of an electrolyte solution
inside a capillary induced by an applied electric field. EOF is caused by charged groups
on the column surface. For example, in silica–based (glass, fused silica, silicon, etc.) CE
columns, silanol (Si-OH) groups are present on the surface. When the solution in the
capillary has a pH value >3, these silanol groups are ionized to form silanoate (Si-O-)
groups. The negatively charged capillary surface will attract positively charged counter
ions from the buffer solution to form two ionic layers (the electrical double layer or
diffuse double layer), as shown in Figure 1.8. The first layer of cations is attracted to the
capillary surface tightly, and is called the fixed layer. The second (or mobile) layer of
cations is further from the capillary surface, and is free to move toward the cathode when
an electric field is applied. This motion of the mobile layer causes the bulk migration of
solution in a capillary. Besides silica-based columns, polymer microdevices can also have
EOF. The rate of EOF is dependent on the electric field and the charge density on the
capillary wall, which can vary with the pH of the buffer solution. In silica-based columns,
EOF will increase with pH until the capillary wall is fully ionized.
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Figure 1.8 Schematic diagram of EOF in a fused silica capillary.
Since EOF is induced by an applied electric field, the electroosmotic velocity (uo) can be
written as

uo = μoE

(1.5)

where μo is the apparent electroosmotic mobility, which can be determined by experiment.
In theory, μo is given by Equation 1.6

μ

o

=

εζ
η

(1.6)

where ζ is the zeta potential of the column and ε is the relative permittivity of the solution.
The zeta potential is dependent on channel surface properties and the pH of the solution in
the column.
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Two methods are commonly used to determine EOF. The first is to measure the retention
time of a neutral analyte during CE [92]; current monitoring [21, 59, 93] is the other
method to measure EOF.
The above discussion indicates that the migration of an analyte in CE is dependent upon
both the rate of EOF and the electrophoretic velocity. Thus, Equation 1.7 defines the net
velocity (u) of an analyte in an electric field.

u = up + uo = (μp + μo)E

(1.7)

In a typical CE system, the EOF is directed toward the cathode. Since analytes in CE
migrate toward the electrode of opposite polarity, negatively charged species migrate
opposite to the EOF direction, while positively charged analytes migrate with the EOF.
Thus, negatively charged analytes are retained longer than positively charged ones.

1.2.2.3 Efficiency and Resolution in CE
In chromatography, theoretical plate counts are used to evaluate the separation
performance. The number of theoretical plates (N) in CE is given by Equation 1.8

N=

μV
2D

(1.8)

where μ is the apparent mobility (electrophoretic plus electroosmotic mobility) in the
separation medium. Thus, the separation efficiency in CE is dependent only on the
applied voltage and analyte diffusion; band broadening in CE is theoretically caused only
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by longitudinal diffusion. This indicates that high performance can be achieved even with
very short separation lengths, provided that heat dissipation is sufficient.
The resolution (Rs) in CE can be written as Equation 1.9.

Rs =

1 ⎛⎜ Δμ p N
4 ⎜⎝ μ p + μ o

⎞
⎟
⎟
⎠

(1.9)

Equation 1.9 indicates that in order to achieve maximum resolution, the electrophoretic
and electroosmotic mobilities should be similar in magnitude, but opposite in sign. In
addition, higher resolution in CE can be achieved with lower net velocity.

1.2.3 Injection
In microchip CE, reproducible injection is critical to separation performance. Because of
the small separation distance and channel dimensions, only a very short plug of sample
should be injected into the separation channel for CE analysis. Otherwise, a large sample
volume will lead to broad bands and decrease the separation efficiency. Currently, most
injection methods for microchip CE are based on electrokinetic effects. Due to the
influence of buffers, pH, ionic strength and EOF, different injection modes are used to
adjust performance and compensate for these variables.

1.2.3.1 Cross Injection
Cross injection was the first method that was introduced in microchip CE [3], and the
mechanism is shown in Figure 1.9. During the sample loading process, an electric field is
applied between reservoirs 1 and 2, which drives sample through the intersection region.
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Once the sample stream is formed, the electric field between reservoirs 1 and 2 is
canceled, and a potential is simultaneously applied between reservoirs 0 and 3. This
electric field will drive the sample in the channel intersection downstream and separate it.
This technique is valuable because repeatable injections are feasible, but cross injection
cannot control sample size reproducibly.
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Figure 1.9 Cross injection. Sample (a) loading and (b) injection.
1.2.3.2 Double-T Injection
Double-T injection was introduced in 1993 [5]. In the sample loading step, a voltage is
applied between reservoirs 1 and 2, while reservoirs 0 and 3 are floated. This voltage will
drive the sample from 1 to 2 (Figure 1.10a). Once the analyte stream has passed the
intersection, reservoirs 1 and 2 are floated, and a separation voltage is applied between
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reservoirs 0 and 3. Thus, the sample plug is loaded into the separation channel for
analysis (Figure 1.10b).
One advantage of double-T injection is that it can control injection plug size more
accurately than cross injection. However, double-T injection has a serious problem of
sample leaking from the injection channel into the separation channel [10]. This issue is
mostly due to convection and diffusion, and it may cause the background signal to
fluctuate and affect resolution.
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Figure 1.10 Double-T injection. Sample (a) loading and (b) injection.
1.2.3.3 Pinched Injection
Pinched injection was first reported by Jacobson et al. in 1994 [11] to address sample
leakage problems of other methods. The scheme of pinched injection is shown in Figure
1.11. During loading, reservoir 2 is grounded, while potentials are applied to reservoirs 0,
1 and 3. For separation, voltage is applied on reservoir 0, while reservoirs 1-3 are
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grounded. In this case, only a well-defined and reproducible sample plug at the channel
intersection will be loaded on the column and separated. Pinched injection can not only
avoid sample leakage, but also provide reproducible sample loading.
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Figure 1.11 Pinched injection. Sample (a) loading and (b) injection.
1.2.3.4 Single-T injection
Single-T injection was among the first generation of injection modes introduced for
microchip CE [4]. The scheme of single-T injection is shown in Figure 1.12. In the
loading step, the sample is driven from reservoir 1 toward reservoir 2 by applying a
potential. Once the sample stream reaches the separation channel, the voltage is
reconfigured and applied between reservoirs 0 and 2 to drive the sample plug into the
channel for CE separation. This scheme is simple, and is still in use today; however,
injection bias for higher-mobility analytes can be introduced.
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Figure 1.12 Single-T injection. Sample (a) loading and (b) injection.
1.2.3.5 Gated Injection
As a continuous sampling method, gated injection was introduced in 1994 [11]. This
method includes three steps, as shown in Figure 1.13. In the first step, two voltages are
applied, one from reservoirs 0 to 2, and the other from 1 to 3. These applied potentials
prevent sample leakage into the separation channel. Next, the voltage from reservoirs 1 to
3 is canceled for a brief (<2 s) time, and a small amount of sample enters the separation
channel due to diffusion. Then, the voltage between reservoirs 1 and 3 is resumed, and the
small sample plug is separated. One advantage of this technique is that it can control the
injection time and amount by careful voltage adjustment.
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Figure 1.13 Gated injection. Sample (a) loading, (b) injection and (c) separation.
1.2.3.6 Optically Gated Injection
Optically gated injection is an advanced method that can produce tiny and reproducible
sample plugs for CE [94] and microchip CE [95]. This technique uses a laser beam to
bleach the sample stream, such that sample plugs are only produced when the laser is
blocked. Optically gated injection can produce picoliter loaded volumes and provide <3%
relative standard deviation in injection reproducibility.

1.2.3.7 Double-L injection
Double-L or low-leakage injection, has been studied by Fu et al. [96, 97]. This method
uses “L”-shaped voltage paths to control the movement of analytes, as shown in Figure
1.14. At first, an “L”-shaped voltage is applied from reservoir 1 to 0 to form the sample
stream (Figure 1.14a). Next, this voltage is canceled, and a new voltage is applied from
reservoirs 2 to 3, driving the sample plug into the separation channel for CE analysis
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(Figure 1.14b). Double-L injection is claimed to be very suitable for biochemical analysis
to gain high resolution, high throughput and precision.
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Figure 1.14 Double-L injection. Sample (a) loading and (b) injection.
1.2.4 Detection Approaches in Microchip CE
1.2.4.1 Optical Detection
UV-absorbance detection is the most commonly used optical detection method for
conventional CE and HPLC. Importantly, native samples can be detected by UV
absorbance. UV detection is also used occasionally for inorganic CE microdevices (e.g.,
glass) [98-100]; but to date little UV absorbance detection has been done in polymeric CE
microchips. Now, things are changing with the development of UV-transparent PMMA
(OP-1) and Topas COC polymers, such that in the future UV absorbance should also find
application in polymer microchip CE systems.
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Laser induced fluorescence (LIF) is the most widely used optical detection method for
microchip CE [4, 5, 10, 17, 21, 22, 35, 53, 101] because most microchip CE materials are
transparent to visible wavelengths of light. Another advantage of LIF is that it has very
low limits of detection. However, most analytes such as proteins and peptides do not have
intrinsic fluorescence at visible excitation wavelengths (e.g., 488 or 532 nm). Thus,
labeling with fluorescent dyes is needed for microchip CE with LIF detection [17, 21, 22].
Several methods have been developed for protein and peptide tagging, including widely
used FITC labeling.
Two-photon excited fluorescence (TPEF) detection has also been introduced for CE [102,
103] and microchip CE [104] to detect the native fluorescence of proteins, peptides and
other analytes. In single-photon florescence, the fluorophore only absorbs one photon in
jumping to an excited electronic state; during relaxation to the ground state, fluorescence
is emitted. In some circumstances a molecule can absorb two photons to transition to an
excited state. In a typical TPEF process, a tightly focused laser beam provides a high
density of photons. If the fluorophore absorbs two photons sequentially within ~1 fs, it
will transition to the excited state. When the fluorophore relaxes to the ground state,
fluorescence is emitted. If two photons are not absorbed sequentially within ~1 fs, no
fluorescence is emitted. TPEF has two advantages when compared to UV and LIF
detection. First, excitation in TPEF is in the visible range. Second, since TPEF is not in
the same wavelength region as the excitation light (in most situations it is at a shorter
wavelength than the source), it is easier to discriminate fluorescence from the excitation
source and background [105].
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IR and Raman detection have not been reported in microchip CE; however, papers have
shown the application of IR [17] and Raman [106] methods in microfluidic devices.

1.2.4.2 Electrochemical Detection
Compared to optical methods, electrochemical detection can be simpler and less
expensive. Moreover, electrochemical detection can be integrated readily into
microfluidic devices. Furthermore, electrochemical methods have low detection limits
(∼0.75 pM) [107] and fast response times (300 ms) [108]. Application of electrochemical
detection in a μTAS system was first reported in 1998 [23] in the amperometric mode.
Since then, conductometry [109, 110] and voltammetry [111] have also been used in
microchip detection.

1.2.4.3 Mass Spectrometry
Mass spectrometry (MS) is a very powerful tool in analytical chemistry, and offers small
sample consumption, high sensitivity and fast analysis time. Moreover, MS can elucidate
the structure of analytes, which is extremely useful in biological applications. Microchip
CE devices have been coupled to MS through electrospray ionization interfaces [112-115].

1.2.5 Surface Modification
1.2.5.1 Dynamic Coating
Dynamic coating is a simple and fast surface modification method. In a typical dynamic
coating process, a surface modifier is added to the separation buffer and flushed through
the channel at a constant speed for a period of time. During this process, the surface
modifier is physically adsorbed onto the channel surface. Adsorbed surface modifier can
reduce EOF and protein adsorption, thus improving CE performance. Species used in
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dynamic coating include charged compounds, neutral polymers, surfactants and
nanoparticles.
Several kinds of charged compounds have been applied in dynamic coating, including
polybrene, dextran, polystyrene sulfonate, poly(allylamine hydrochloride) and lowmolecular weight charged compounds (e.g., mono-, di-, and triethylamines) [39, 116-118].
The molecular weight of the surface modifier is important to the coating performance. For
large polymers, hydrophobic interactions of analytes with the coating may induce peak
tailing [39]. However, low-molecular-weight charged compounds cannot effectively
cover all the channel surface, which means that biomolecule adsorption on surfaces may
not be eliminated [118].
Neutral hydrophilic polymers are used in CE to reduce biomolecule adsorption to the
column surface [87, 119]. To reduce nucleotide adsorption, mixtures containing
hydroxypropyl methylcellulose (HPMC), mannitol, glucose, glycerol and poly(ethylene
glycol)-poly(propylene glycol)-poly(ethylene glycol) copolymer have been used [87, 119].
To

reduce

protein

and/or

peptide

adsorption,

poly(ethylene

glycol)

(PEG),

hydroxyethylcellulose, HPMC, poly(N,N’-dimethylacrylamide) and methylcellulose have
been used [88, 118].
Other commonly used compounds for dynamic coating include surfactants, which are
used to dynamically coat hydrophobic surfaces. Because surfactants have both
hydrophobic and hydrophilic ends, they can be adsorbed on surfaces through hydrophobic
interactions. Once surfactants are aligned on a surface, their hydrophilic ends extend
outward and change channel surface properties. Reported surfactants used for dynamic
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coating

include

Brij35,

Brij76,

Brij78,

cetyltrimethylammonium,

dodecyltrimethylammonium, dodecyl sulfate and tetrabutylammonium [89, 118-121].
Recently, gold nanoparticles (GNP) have been used with polymers for dynamic coating.
[122, 123]. GNPs increase the viscosity and stability of the coating, thus improving CE
performance.

1.2.5.2 Permanent Surface Modification
Although dynamic coating is the simplest method for surface modification, its effects do
not last long. Compared to dynamic coating, permanent surface modification is complex
and lab intensive, but it is more effective. Two methods have been used for permanent
surface modification. One is conducted by specific chemical reactions to modify the
surface chemistry, while the other method uses a high energy source to activate or alter
the chemical structure of the surface.

Surface Modification of Inorganic Microdevices. Since most inorganic materials used
for microdevices are silica-based (glass, quartz, etc.), they can be derivatized using silane
chemistry [124-126]. The surface modification of inorganic microdevices is not closely
related to my research, so further details will not be given here.

Oxygen Plasma Treatment. Oxygen plasma treatment is a simple and rapid method for
polymer surface modification. This method utilizes a high energy plasma to form
hydrophilic structures on polymer surfaces, such as on PDMS [53] or TPE [59]. However,
the hydrophilic effect induced by the plasma does not last long, so in most cases, oxygen
plasma treatment is used to activate the polymer surface for the immobilization of other
functional

groups.

For

example,

alkyltrichlorosilanes

[127],

2-

36

[methoxy(polyethyleneoxy)propyl]

trimethoxysilane

and

poly(ethylene

glycol)

di(triethoxy)silane [128] have been immobilized on plasma-activated PDMS surfaces to
reduce protein adsorption.

UV Radiation Treatment. UV radiation is another high-energy source for surface
modification of polymer materials. UV radiation can generate high-energy, short-lived
free radicals on polymer surfaces. If a monomer solution is present on the surface, these
free radicals can initiate polymerization [129-131]. However, one-step UV-activated
grafting requires a high dose of UV radiation, and polymerization is not easily
controllable, which often leads to channel clogging. Thus, “surface-directed” graft
polymerization was developed [131, 132] in which PDMS is first immersed in an organic
solution that contains free radical initiators (photoinitiator or thermal initiator) to adsorb
them into the PDMS. Then, the PDMS is taken out of solution, dried and transferred into
an aqueous solution of a hydrophilic monomer. After this step, heat or UV radiation is
used to activate the graft polymerization of monomer on PDMS. Using this method, a
uniform layer of a hydrophilic polymer can be grafted on the PDMS surface. Peptide
separations were shown in PDMS devices coated by this method, indicating its
effectiveness in permanent surface modification [130].

Atom Transfer Radical Polymerization. Atom-transfer radical polymerization (ATRP)
[133-135] has been used for chemical modification of PDMS [33, 136] and PMMA [21]
microchannels. ATRP modification of plastics involves activation of the surface via
plasma oxidation, immobilization of the initiator, and subsequent grafting of the chosen
polymer to the surface (see Section 3.2.3 and Figure 3.3). In ATRP, the length of
polymer attached to the surface can be controlled readily. ATRP has been used in surface
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attachment of various polymers, including polyacrylamide [137], hydroxypropyl cellulose
[138], methacrylate [139], PEG [21], and peptidoglycans [140]. Typically, neutral
polymers are used to eliminate electrostatic interactions with analytes. PEG-modified
PMMA devices have shown improved separation performance relative to unmodified
ones [21].

1.3 Affinity CE for Cancer Marker Protein Analysis
1.3.1 Cancer Marker Proteins
1.3.1.1 Introduction
Cancer markers are species, such as proteins, hormones, small molecules, etc., which are
produced by cancer cells or by the body in response to cancer [141-143]. These moieties
are called “markers” because they are associated with cancers, or at least their
identification and measurement can be used to evaluate the existence and potentially the
stage of cancers. Cancer markers can be found in blood, urine and body tissues, and their
concentrations are several orders of magnitude lower than abundant proteins (such as IgG,
hemoglobin and albumin) [142, 144].
Cancer markers can be used for the following purposes: 1) to monitor people or high risk
populations for cancers, 2) to diagnose the existence of cancers, 3) to determine the stage
of an existing cancer, and 4) to monitor cancer recurrence during or after treatment [142,
143]. An ideal cancer marker should meet all of the above four purposes, and any assay
should be 100% sensitive, without false negatives. However, none of the currently known
cancer markers can do this. Most cancer markers are neither sensitive nor specific enough
to diagnose cancer without the support of other clinical tools. It is also possible for a
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cancer patient to have similar marker levels to a healthy person. Importantly, cancer
markers do have the potential to help doctors diagnose cancer.
Several commonly known cancer markers include human chorionic gonadotropin (hCG),
a marker for testicular cancer; carcinoembryonic antigen, a marker for colorectal cancer;
prostate-specific antigen, a marker for prostate cancer; alpha-fetoprotein, a marker for
hepatic and testicular cancers; cancer antigen 125, a marker for ovarian cancer; and
cancer antigens 15-3 and 27.29, markers for breast cancer.

1.3.1.2 Human Choronic Gonadotropins and Their Analysis
Human chorionic gonadotropin is well known as the analyte that is probed in pregnancy
tests [145]. It is a peptide hormone produced by human females and is overexpressed in
pregnancy. The hCG protein is composed of 244 amino acids (heterodimeric with 2
subunits) with a molecular mass of 36.7 kDa [146]. The α subunit has 92 amino acids and
is identical to that of the luteinizing hormone, follicle-stimulating hormone, and thyroidstimulating hormone. The β subunit is unique to hCG but shares some common amino
acid sequences with the α subunit [144, 145]. In biological fluids, hCG appears as intact
hCG, free α subunit, free β subunit, and various fragments such as nicked hCG and nicked
free βhCG.
In pregnancy, hCG is overexpressed, and its level can increase over 10,000 fold during
pregnancy [145]. For example, non-pregnant females have hCG levels lower than 5.0
mIU/mL in blood, a woman in her first two months of pregnancy will have an hCG level
as high as 5000-200,000 mIU/mL, and a female in her 3rd trimester will have hCG levels
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between 1000-50,000 mIU/mL [147]. Thus, hCG levels provide an excellent diagnostic
marker for pregnancy.
The β subunit of hCG is also overexpressed in some cancers including teratomas,
choriocarcinomas (often found in the testes and ovaries) and islet cell tumors (e.g., in the
brain as dysgerminoma) [145, 148]. Thus, both hCG and free βhCG should be detected in
individuals with these cancers, and an elevated level of total hCG should occur. However,
for females, elevated hCG levels are not always linked to cancer occurrence. Also,
women with low hCG levels are not totally excluded from cancer risk. Since males don’t
normally produce βhCG, any detectable βhCG level indicates a high risk of cancer.
Moreover, once cancer is diagnosed, hCG levels are useful for doctors to ascertain the
effects of cancer treatments. After a successful treatment, the patient’s hCG level is
expected to drop [142, 145, 149].
Currently, detection of hCG involves immunological means, such as enzyme-linked
immunosorbent assay (ELISA), radioimmunoassay (RIA) and western blotting, which
normally gives a “true” or “false” result [145]. This is sufficient to diagnose pregnancy,
but for cancer, a “true” or “false” result is not enough, because the level of hCG in a
patient correlates with the existence, stage, or recurrence of cancer. In cancer diagnosis,
two different hCG antibodies (anti-α- and anti-βhCG) should be used. The anti-βhCG
antibody will give the total hCG amount, while the anti-αhCG antibodies give only the
level of intact hCG in the sample. The difference between these two results yields the
amount of βhCG in the sample, which is very useful for cancer diagnosis. Unfortunately,
this dual antibody method is expensive, labor intensive, and time consuming, such that a
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new approach should be developed for detection of both hCG and βhCG. In Chapter 5, I
further discuss the potential of one such approach.

1.3.2 Affinity Methods for Cancer Marker Detection
1.3.2.1 Protein Analysis
Biological samples such as blood, urine, and body fluids are very complex, and may
contain hundreds or even thousands of different proteins [150, 151]. For example, ~500
distinct proteins have been identified in serum using on-line reversed-phase micro
capillary liquid chromatography coupled with ion trap MS [152]. In samples like blood,
protein concentrations range widely from 50 mg/mL for albumin [153] to several ng/mL
for some cancer markers [154, 155]. When cells/tissues are damaged (as in some cancers),
cellular proteins can also escape into the blood or intravascular fluids.
Currently, the most prevalent method in proteomics is two-dimensional (2D) gel
electrophoresis [156, 157], which can isolate more than one thousand protein bands in a
sample. However, this technique is expensive, labor intensive, time consuming, and not
reproducible. Also, 2D gel electrophoresis cannot resolve both large and small proteins,
and analyte recovery from the gels is limited, due to the low mass loading (<300 μg).
Moreover, numerous treatments need to be done before and after the sample is separated
by 2D gel electrophoresis, because this method cannot automatically select the target
proteins in a complex sample. Thus, although 2D gel electrophoresis is effective for
protein analysis, it is still a bottleneck in proteomic studies. Besides 2D gel
electrophoresis, other approaches such as 2D liquid-phase separation [158] and 2D liquid
chromatography [159] have been developed to improve performance in protein analysis,
but more work still needs to be done.
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1.3.2.2 Applications of Affinity Techniques in Cancer Marker Analysis
In Section 1.3.2.1, I discussed the current methods for protein analysis and concluded that
no approach is ideal. Also, in many situations it is not necessary to identify all the
proteins in a sample when one only needs to know the concentrations of certain target
proteins. For this reason, affinity techniques have become popular in many assays
involving cancer markers.
Affinity methods are based on the strong and selective interaction between antibody and
antigen. For cancer diagnosis, normally one only needs to quantify several marker
proteins in a mixture that may have numerous types of other proteins; thus, it is not
necessary to separate and isolate every protein in the sample. Affinity techniques can be
used to extract and concentrate proteins of interest from a sample mixture. These
advantages of affinity methods explain why so far, most approaches for cancer diagnosis
are based on immunological techniques, such as RIA [160], ELISA [161] and western
blotting [162].

1.3.2.3 Monolithic Columns
The use of a monolith was first demonstrated by Hjerten in 1989 [163]. The monolith was
originally called a continuous bed or continuous polymer bed. Monolithic columns
contain continuous rods with micrometer-dimension canal-like through pores and
nanometer-size pores within the bed structure. These structures are formed in a column by
polymerization/sol-gel reaction, so compared with conventional packing, monolithic
materials require lower pumping pressures (lower back pressure), and no frit is needed
[164-167].
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There are two types of monoliths. Those based on a silica backbone are synthesized using
a sol-gel reaction in a mold [168-170]. This type of monolith is typically hydrophobic
after surface derivatization and is only suitable for the separation of small molecules.
Thus, I will not discuss these in detail here. The second type of monolith includes
polymer monoliths, which are typically prepared in situ using UV or thermal
polymerization of solutions composed of a monomer, crosslinker, porogen, and initiator
[164-167, 171]. Polymerization can be initiated using a redox system (e.g.,
tetramethylethylenediamine and ammonium persulfate) or a free radical initiator (DMPA).
The detailed mechanism of monolith formation is not completely known, but it is believed
that the porogen aids in the formation of the monolith structure and pores.
One advantage of a monolithic material is that it has high chemical resistivity, which
makes it suitable for use under extreme conditions. Also, because monoliths can be
polymerized inside columns and covalently attached to the surface, no frit or fitting is
needed. The large canal-like through pores ensure high mass transfer rates and low flow
resistance; while nanometer-size pores create faster diffusion between the mobile and
stationary phases. Consequently, rapid and high-quality separations can be achieved in
monolith columns, and polymeric monoliths have been proposed as phases for antibody
attachment [137, 165, 172].
In Chapter 5, I discuss a monolith based on glycidyl methacrylate (GMA), which has a
hydrophilic surface. Both basic and acidic model proteins have been separated
successfully in such columns [165, 171]. Importantly, the reactive epoxy groups on the
GMA monolith surface make it a perfect candidate for antibody attachment.
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1.3.3 Immobilization of Antibodies on GMA Polymer Monoliths
Since GMA epoxy groups in monoliths are reactive, considerable effort has been placed
on attachment of proteins of interest to these surfaces. Currently, there are four methods
that can perform antibody attachment successfully on GMA monoliths.

1.3.3.1 Direct Attachment
The active epoxy groups present on GMA monoliths can react directly with an amino
group of a protein to form a covalent linkage [164]. Armenta et al. successfully attached
protein G to a GMA monolith using this method [165, 171]. Protein was first dissolved in
pH 9.2 carbonate buffer and flushed through the GMA monolith. Then both ends of the
column were sealed and the monolith was heated for 20 h at 34 ºC. However, this
attachment needed a high concentration of protein sample (>1 mg/mL), long reaction time
and somewhat elevated temperature. Moreover, because most proteins have both terminal
and side chain amino groups, direct amine reaction cannot control the orientation of a
protein attached to a monolith. The orientation of antibodies on the surface is critical to
function and activity.

1.3.3.2 Acid Hydrolysis Followed by Oxidation
An alternative to direct attachment is acid hydrolysis followed by oxidation (Figure 1.15)
[137, 173]. Typically, the surface GMA groups are first hydrolyzed, followed by
oxidation using periodate. Then the activated aldehyde groups can react with protein
amine functionalities to form an imine (–C=N-) group. Because the imine group is not
very stable, it needs to be reduced to –C-NH- to increase attachment robustness.
Compared to direct attachment, this method is more effective, particularly with respect to
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reaction time and efficiency. However, this technique cannot control the orientation of
proteins attached to the surface.

Figure 1.15 Attachment of protein to a GMA monolith by acid hydrolysis/oxidation.
1.3.3.3 Aminolysis Followed by Dialdehyde Activation.
Another method to immobilize proteins on GMA monoliths uses aminolysis followed by
dialdehyde reaction (Figure 1.16) [174-176]. In this method, the epoxy groups are first
reacted with a diamine, followed by activation with a dialdehyde to extend the length of
the anchoring chain. The terminal aldehyde groups on the anchoring chain can then react
with protein amine groups to attach them to the monolith. Finally, the imine groups are
reduced, as in Section 1.3.3.2. One advantage of this approach is that the anchoring chain
is extended so the attached protein has greater orientational flexibility. Moreover, this
method is well-developed. However, this technique cannot control the orientation of
attached proteins.
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Figure 1.16 Attachment of protein to a GMA monolith by aminolysis and dialdehyde
activation.
1.3.3.4 Hydrolysis Followed by Carbonyldiimidazole Activation
Hearn et al. [177] first proposed this attachment approach; in 2004, this method was used
to attach trypsin on GMA [178]. The mechanism of attachment is shown in Figure 1.17.
After acid hydrolysis, the GMA surface is reacted with carbonyldiimidazole (CID), which
has high reactivity toward amine groups, and can be used to link proteins to the monolith.
Unreacted CID groups on the GMA monolith can be quenched by Tris buffer or aspartic
acid solution. One advantage of this method is that the reaction between CID and protein
is very fast; furthermore, a literature report indicates that this method can provide better
column performance than direct attachment [178]. However, the orientation of the
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attached proteins is not controlled in this approach.
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Figure 1.17 Attachment of protein to a GMA monolith by hydrolysis and CID
activation.
1.3.3.5 Attachment of Antibodies to Surfaces Using the Pierce Method
Pierce (Rockford, IL) has a standard method for oriented antibody attachment to glass
surfaces [179]. Briefly, a glass surface is first treated with 3-aminopropyltriethoxysilane,
which will create amine groups. Then, a crosslinker which can react with both amine and
thiol groups is attached to the amine-modified surface. Next, the antibody is partially
reduced to create free thiol groups, and this protein reacts with the surface. This method
has the unique feature of controlling orientations of attached antibodies to retain activity.
The disadvantages of this method are that it requires multiple steps and is complicated.
My antibody attachment procedure has a similar mechanism, and details will be discussed
in Chapter 5.
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1.4 Electric Field Gradient Focusing (EFGF)
1.4.1 Principle of EFGF
Field-gradient methods were first defined by Giddings [180] as techniques that can isolate
and focus analytes at certain points under different gradients/forces. EFGF is an
equilibrium-gradient method for charged analytes in which a constant flow is created in
one direction while a gradient in electric field is applied in the opposite direction. As
shown in Figure 1.18, when a charged analyte is introduced into an EFGF device, it will
be driven by the constant flow in one direction, countered by electrophoretic migration in
an electric field gradient in the opposite direction. Since the electric field varies along the
column, a given protein will have a different electrophoretic velocity, depending on its
position in the channel. When the electrophoretic and flow velocities of a protein are
opposite in direction and equal in magnitude, the protein will be focused at that point in
the EFGF channel. Since proteins normally have different electrophoretic mobilities, they
will focus at distinct positions in an EFGF device.

Figure 1.18 Scheme of EFGF; proteins are focused based on the equilibrium
between electrophoretic velocity and constant flow.
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Compared to other protein separation techniques, EFGF has several advantages. First,
EFGF has the potential to provide high resolution and peak capacity [72, 181, 182].
Theoretical studies have shown that EFGF should be able to separate two proteins with a
pI difference of less than 0.001 [183]. Moreover, EFGF parameters can be adjusted easily;
by simply changing the applied potential or flow rate, one can control the movement and
focusing position of analytes. In addition, EFGF can be used to trap selected proteins of
interest in a column. Other proteins, which have either too high or too low electrophoretic
mobilities, will not be kept inside the EFGF channel. Last, EFGF can concentrate analytes
while they are being separated. Since most cancer markers are many orders of magnitude
lower in concentration than major serum proteins (such as IgG and albumin), the last two
advantages are very important in cancer marker analysis.
Two types of EFGF devices have been developed in our laboratories. One is capillary
based [72], as shown in Figure 1.19. The other is microchip based, and uses either a
sacrificial layer [184] or a weir structure [185] instead of a wire to define the EFGF
channel.
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Figure 1.19 Fabrication and operation of a capillary-based EFGF device. (a) Two
PMMA plates and two capillaries with a suspended wire are needed to prepare a
device. (b) The assembly is formed by thermal bonding. (c) The conductive gel is
polymerized. (d) The wire is removed to make the final EFGF device. (e) Operation
of an EFGF device: a syringe pump is connected to the left capillary to provide flow.
Sample can be injected from the reservoir by the applied electric field, or from the
syringe pump.
A protein mixture containing green fluorescent protein (GFP) and R-phycoerythrin (R-PE)
can be separated successfully using such EFGF devices (Figure 1.20). Microchip-based
EFGF systems have better resolution than the capillary-based setup, because of the
smaller channel dimensions and lower laminar flow dispersion compared to capillarybased EFGF devices.
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Figure 1.20 EFGF focusing of two proteins, GFP and R-PE in (a) microchip-based,
and (b) capillary-based EFGF devices. Reprinted with permission from [184]
(copyright 2006 American Chemical Society).
1.4.2 Advantages of Affinity-Coupled EFGF
As discussed in Section 1.3.2.1, current methods for cancer marker analysis have some
disadvantages, and new techniques should be developed. Affinity-coupled EFGF is a
potentially advantageous candidate for high-performance cancer marker analysis,
compared to conventional methods. First, this technique should be simpler and less
hazardous because it does not need either radioactive materials or addition of secondary
antibodies, as in RIA, ELISA or western blotting. Moreover, EFGF patterns can be
adjusted readily by changing the flow rate or applied potential. Affinity-coupled EFGF
should also allow selection and concentration of target proteins from a complex biological

51

sample without interference from other analytes. I believe affinity-coupled EFGF has
broad potential in protein analysis.

1.5 Dissertation Overview
My dissertation work focused on three general areas of miniaturized analysis. The first
project involved the development of new microdevices made of CaF2 as described in
Chapter 2. A method was devised for machining enclosed CaF2 microchannels, and amino
acid separations were carried out in these microdevices. Moreover, on-chip IR detection
was performed for the first time on these microchips. My second area of emphasis was the
surface modification of polymer microdevices to improve their CE performance in
bioanalytical applications. Two different polymers, PMMA and TPE, were derivatized
covalently using ATRP. Microchip CE of proteins, peptides and amino acids was used to
test the performance of surface-modified PMMA and TPE microdevices. Derivatization
and characterization of surface-functionalized PMMA and TPE microchips are presented
in Chapters 3 and 4, respectively. Chapter 5 describes the development of an affinity
column−CE system for the selective enrichment and CE separation of hCG, which could
be used for cancer marker analysis. I developed a new method to attach oriented
antibodies on monoliths such that activity was retained. Finally, conclusions and future
directions are discussed in Chapter 6.
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Chapter 2. Fabrication of CaF2 Capillary
Electrophoresis Microdevices for Online IR
Detection*
2.1. Introduction
Miniaturization of tools for chemical analysis offers significant advantages [1] in terms of
speed, throughput, and reagent consumption. The benefits of decreased size in separation
methods are illustrated best by the significant advances in microchip capillary
electrophoresis (CE) technology during the past decade [2]. Laser-induced fluorescence
(LIF) detection at visible wavelengths was used in the initial demonstration of the
microchip CE concept [1], and this detection scheme continues to enjoy broad use at
present [3]. LIF detection at ultraviolet (UV) wavelengths [4] or in the near infrared (IR)
[5] is less commonly utilized, although detection in these regions of the spectrum offer
distinct advantages in terms of chromophore availability for UV wavelengths and
reduced background for the near IR region.
Many different substrates have been used for construction of microfluidic electrophoresis
systems, including glass [6-9], quartz [4], silicon [10] and polymeric materials [11-13].
Borosilicate glass is transparent from 350 to 2000 nm [14], but detection with devices
composed of this material is not possible beyond the near IR or in the UV region of the
* This chapter is reproduced with permission from J. Chromatogr. A 2004, 1027, 231-235. Copyright 2004
Elsevier.
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spectrum. The use of quartz substrates for microchip CE enables UV detection [4], but
useful IR, as well as the shorter UV wavelengths still remain inaccessible. Maximum
versatility in optical detection methods for laboratory-on-a-chip systems would be
achieved with substrate materials having the broadest wavelength transmission ranges.
Microdevices composed of such materials would allow not only quantitative analysis by
probing samples in one region of the spectrum (e.g. UV or visible), but also qualitative
analyte identification by IR spectroscopy. CaF2 is an ideal candidate material for such
experiments because it has a transmission range of 170–7800 nm [15]. Indeed, a recent
report demonstrated the successful coupling of an IR-transparent CaF2 flow cell with a
conventional fused silica capillary for end-column Fourier-transform (FT) IR detection in
CE [16]. However, the post-column coupling of a CaF2 cell with a capillary column
increases instrumental complexity and can contribute to band broadening. Ideally, IR
detection should be performed on column, but this approach requires the construction of a
separation system with suitable optical properties.
Here, I present the fabrication and use of microfluidic CE devices made from CaF2
substrates. The application of these devices to chemical analysis was demonstrated by the
separation of fluorescently labeled amino acids. Also, on-chip IR detection in
microfluidic channels was accomplished for the first time, demonstrating the potential for
separating, quantifying, and spectroscopically identifying analytes in a microfluidic
platform.

67

2.2 Experimental Section
2.2.1. Microfabrication
Fabrication of CaF2 CE microdevices is depicted schematically in Figure 2.1. Briefly, the
microchips were made by photolithographic patterning, followed by chemical etching of
CaF2 substrates in a saturated aqueous Fe(NH4)(SO4)2 solution. Each etched CaF2 piece
containing the channel design was then bonded to a second, photoresist-patterned CaF2
substrate to form microcapillary structures.
Conventional photolithographic procedures were used to pattern the microchannel and
cover plate following previously reported work [17]. The microchip CE device pattern
consisted of 100 μm wide channels with a simple cross-injector [6, 9]. The injection
channel was 1.5 cm long, while the separation channel was 2.0 cm long, and the injection
channel intersected the separation channel 0.5 cm from reservoir 2 (Figure 2.1f). CaF2
substrates of 1.0 in. diameter and 0.12 in. thickness (Casix, Chatsworth, CA, USA) were
spin coated with 1.1 μm of S1813 photoresist (Shipley, Marlborough, MA, USA; Figure
2.1a; 1 in. = 2.54 cm). Next, the microfluidic design was transferred to the photoresist, as
illustrated in Figure 2.1.b, and the unpatterned side of each substrate was coated with
acrylic fingernail polish to prevent backside etching. The exposed channel areas were
etched in a saturated aqueous Fe(NH4)(SO4)2 solution for 24 h at room temperature
(Figure 2.1c); the etchant solution was stirred using a Teflon-coated spin bar rotating at
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100–120 rpm. After etching, the residual photoresist and fingernail polish were removed
using acetone.

Figure 2.1. Fabrication of CaF2 microdevices for CE. (a) The CaF2 substrate (white)
is spin-coated with photoresist (gray). (b) Exposure and development of the
photoresist provides the surface pattern on the CaF2. (c) The substrate is etched in
unmasked areas. (d) The etched CaF2 piece is aligned with the patterned photoresist
on another CaF2 substrate, and the two pieces are brought into contact. (e) The
aligned CaF2 plates are clamped and heated to cause the photoresist to bond the
substrates together. (f) Photograph of a bonded CaF2 microchip. The substrate
diameter is 1 in. Reservoirs are (1) injection, (2) buffer, (3) injection waste and (4)
high voltage. The injection channel runs between reservoirs 1 and 3, while the
separation channel connects reservoirs 2 and 4.
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Access holes were drilled using a 0.021 in. carbide drill bit (Federal-Mogul, Chicago, IL,
USA) to form each of the four buffer reservoirs in the etched CaF2 substrate. A second
CaF2 piece was spin coated with Shipley S1813 photoresist and patterned like the first,
but with a channel width of 200 μm, rather than 100 μm, as shown in the top half of
Figure 2.1d. This created an optically transparent window over the entire etched
microchannel structure. The photoresist served as an adhesive to bond the two substrates
together [16] once they were aligned under a microscope, clamped together, and placed
in an oven at 135 °C for 30 min (Figure 2.1e). Elevated temperature treatment was
necessary to develop the full mechanical strength and chemical resistance of the Shipley
S1813 photoresist. An Alpha-step 200 stylus profilometer (Tencor, Mountain View, CA,
USA) scanned with 2 μm lateral resolution was used to measure the dimensions of the
etched CaF2 patterns.
2.2.2 Separation and detection of amino acids
Glycine, arginine, and phenylalanine were purchased from Sigma (St. Louis, MO, USA)
and diluted in the run buffer, 30 mM borate, pH 9.0. The borate buffer was filtered using
a 0.2 μm pore diameter filter (Pall, East Hills, NY, USA) prior to use. Each amino acid
was labeled fluorescently by conjugating fluorescein 5-isothiocyanate (FITC, Sigma) to
the amine group [9, 17]. All FITC-tagged amino acids had a concentration of 300 μM in
borate buffer after labeling.

70

Channels were filled by micropipetting 20 μl of run buffer on top of reservoirs 1, 2, and 3
and applying vacuum to reservoir 4 (see Figure 2.1f for reservoir layout), after which
reservoir 4 was covered with 20 μL of run buffer. One microliter of sample was
transferred into the bottom of reservoir 1 using a 25 μL syringe, and platinum electrodes
were inserted into all buffer reservoirs to provide electrical contact. “Pinched” injection
[7] for 10 s was used to load sample on the column prior to separation, and the injection
volume was ∼400 pL. During injection, reservoirs 1, 2, and 4 were grounded and
reservoir 3 was maintained at +0.6 kV; for separation, reservoirs 1 and 3 were held at
+0.6 kV, reservoir 2 was grounded, and reservoir 4 was maintained at +1.0 kV. The LIF
detection system and the setup for data acquisition have been described elsewhere [17].
The sampling rate for data collection in the software was chosen to be 5 Hz.
2.2.3. FT-IR spectrometer
An FT-IR microscope comprised of a Nexus 670 FT-IR spectrometer (Nicolet, Madison,
WI, USA) and an IR-Plan IR Microscope Accessory (Spectra Tech, Stamford, CT, USA)
was used for on-column IR detection. The CaF2 microdevice channels were filled with
toluene (Fisher, Pittsburgh, PA, USA). To enable the IR beam to be focused correctly, the
CaF2 microdevice was placed in an external optical focusing unit, constructed in the
laboratory, in a Perspex unit purged with dry air. The IR beam from an external optical
port of the spectrometer was focused on the injection intersection region of the CaF2
microdevice by means of an off-axis parabolic mirror, prior to impinging on a mercury
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cadmium telluride detector. Sixty-four scans were co-added for each spectrum, and the
spectral resolution was 4 cm−1. Reference measurements on toluene were obtained using
1 in. diameter CaF2 windows with 100 μm spacing between the plates.

2.3. Results and Discussion
2.3.1 Fabrication
I have fabricated CaF2 microdevices for rapid biochemical analysis and flexible optical
detection. To generate microfluidic structures in CaF2, it was necessary to develop
methods for etching this material. Although CaF2 can be etched by laser-induced heating
[18] or accelerated ion beams [19], these approaches require costly and sophisticated
instrumentation. Thus, I explored methods for the wet etching of CaF2 and found
saturated aqueous Fe(NH4)(SO4)2 to be a suitable choice. I also determined that the etch
rate of the CaF2 is dependent on the stirring of the etchant solution. In an unstirred
solution, the etch rate is ~8 μm per day, while in a stirred solution the etch rate can be
increased to as much as 18 μm per day. These etch rates are sufficient for fabricating
microfluidic arrays in CaF2. I believe the etching mechanism involves the reaction of Fe3+
ions in solution with F− ions in CaF2 to form the coordination complex [FeF6]3−. Stirring
the etchant solution also helped to prevent the precipitation of byproducts on the channel
surface, which hindered the etching process.

72

The channel width designed in the photomask was 100 μm; however, I observed some
undercutting of the photoresist protecting layer such that the width of the etched channels
typically exceeded the photomask linewidth. I also observed that etchant stirring speeds
of 100–120 rpm produced the narrowest channel features, typically having ~200 μm top
widths. Profilometry measurements indicated that the channels in the CaF2 microdevices
used for separation experiments had depths of ~10 μm, top widths of ~200 μm, and
bottom widths of ~100 μm.
Developing a reliable procedure for bonding two CaF2 substrates together to form
enclosed microcapillaries proved to be somewhat difficult, because of the crystallinity
and high melting temperature of CaF2. I tried to bond CaF2 wafers using water, acid,
ferric ammonium sulfate solution, or aqueous EDTA under a range of temperatures from
25 to 1100 °C. However, none of these methods produced adequate, water-stable bonding.
Thus, I opted to use a 1.1 μm layer of Shipley S1813 photoresist to adhere the CaF2
substrates together [16]. I found that this bonding approach provided sufficient
mechanical strength, chemical resistance to aqueous buffer solutions, and stability in the
presence of elevated voltages to be compatible with CE experiments. Another advantage
of this method is that the bonding photoresist can be photolithographically patterned to
leave an optically transparent window along the length of the etched channels. Finally,
the thin photoresist layer appears to cause minimal band broadening in these devices,
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even though different materials defining a channel cross-section can create
inhomogeneities in ζ-potential [20, 21].
2.3.2 Amino Acid Separations
To demonstrate the utility of CaF2 microchips for biological analysis, I performed CE
separations on a mixture of fluorescently labeled amino acids. Separation and detection
were performed as described in Section 2.2.2. Figure 2.2a depicts electropherograms of
individual amino acids (glycine, arginine and phenylalanine) injected and detected in a
CaF2 microdevice. The electropherograms show that each amino acid eluted within 25 s,
and the peaks were symmetrical to some extent, while they were somewhat broad. This is
possibly due to two reasons. First, the photoresist used for device bonding might cause
analyte adsorption on the channel surfaces. Second, the length of separation channel (1.5
cm) was not long enough to give a high separation performance. However, these results
indicate the suitability of CaF2 as substrate for rapid electrophoretic analysis of biological
samples. Figure 2.2b shows a ~30 s separation of a mixture of the same three FITClabeled amino acids. Peak fitting was used to deconvolute the partially overlapping
analyte bands in this separation, and Figure 2.2c displays the results of peak fitting. Three
individual components, corresponding to glycine, arginine, and phenylalanine are
observed, based on comparison with migration times in Figure 2a. Importantly, the sum
of the component peaks closely approximates the experimental data in Figure 2b.
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Figure 2.2 Electropherograms of FITC-labeled amino acids separated using a CaF2
microdevice. (a) Injection and detection of individual FITC-tagged amino acids: (1)
Gly, (2) Arg and (3) Phe. (b) Separation and detection of a mixture of FITC-labeled
Gly, Arg, and Phe. (c) Peak fitting of the electropherogram in (b) shows three
distinct components (solid, dotted and dashed black lines) with migration times
similar to those in the individual runs in (a). The sum of the fit to the data is
indicated by the gray line in (c). Potentials for injection and separation in all runs
are described in Section 2.2.2.
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2.3.3 FT-IR Experiment
FT-IR microscopy was used to test the possibility of using IR spectroscopy for on-chip
analyte identification in CaF2 microdevices. I filled the channels with toluene, water, and
acetonitrile, respectively, in separate experiments, and obtained IR absorbance spectra.
Figure 2.3a depicts the FT-IR absorbance spectrum of toluene in the injection area of a
microchannel in a CaF2 microdevice, while Figure 2.3b shows an IR absorbance
spectrum of toluene using standard CaF2 windows. Comparison of the spectra in Figure
2.3 confirms that toluene within the microchannels can be detected and identified readily,
even though the absorbance in Figure 2.3a is lower than in Figure 2.3b because the
optical path length was ~10× shorter. Similar agreement between absorbance spectra in
microchannels and the sample cell was observed for water and acetonitrile (data not
shown). Moreover, the IR spectrum in Figure 2.3a agrees well with the toluene reference
IR spectrum in the NIST online database [22], indicating that CaF2 microdevices are
suitable for on-chip IR detection and analyte identification. In these experiments I set the
resolution to 4 cm−1 to obtain high-resolution IR spectra. However, for real time detection
in CE or other separation methods, lower spectral resolution should provide sufficient
detail for qualitative analysis, and the decreased optical measurement time should enable
higher temporal resolution.
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Figure 2.3 FT-IR detection in CaF2 microchannels. (a) FT-IR spectrum of toluene in
the injection region of a microchannel in a CaF2 microdevice. (b) FT-IR spectrum of
toluene in a standard CaF2 IR cell.

2.4 Conclusion
I have successfully developed methods for the design and fabrication of CaF2
microfluidic devices for maximum flexibility in optical detection. CE of FITC-labeled
amino acids has been performed, and the results indicate that CaF2 provides a suitable
platform for rapid biochemical separations. Moreover, FT-IR tests indicate that CaF2
microfluidic devices are suitable for real time, on-column FT-IR identification of analytes
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in microchannels. These CaF2 microchips should enable both quantitative and qualitative
optical analyses in laboratory-on-a-chip systems.
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Chapter 3. Microchip Protein and Peptide
Separations in Polymeric Devices
3.1 Introduction
Interest in the characterization of proteomes has expanded greatly in recent years. The
proteome is the entire complement of expressed proteins in a cell or tissue [1]. Proteome
characterization is valuable in gaining a fundamental understanding of complex
biological processes, such as cell death, cell differentiation, cell development, signal
transduction, etc. Proteomes can vary considerably among different cells or tissue types,
and many factors can affect the protein patterns in a cell or tissue (diseases, chemicals,
stress, malfunctions, misfunctions, etc.) [2-4]. Thus, protein analysis (i.e., separation,
identification and quantification of proteomes) is very important.
Currently, the most effective method for protein analysis is two-dimensional (2D) gel
electrophoresis [5, 6], which can isolate more than one thousand protein bands in a
sample. However, this technique is expensive, labor intensive, time consuming, and not
reproducible. Moreover, numerous treatments need to be done before and after the
sample is separated by 2D gel electrophoresis because this method cannot automatically
pick the target proteins out from a complex sample. Thus, although 2D gel
electrophoresis is somewhat effective for protein analysis, it is still a bottleneck in
proteomic studies.
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Since the fundamental theory of modern capillary electrophoresis (CE) was first
described by Jorgenson and Lukacs [7, 8], CE has become a powerful tool for protein
analysis [9-13]. Compared to other protein analysis methods, CE has several advantages,
including high sensitivity, good resolving power, low sample consumption and ease of
automation. With the rapid development of micro total analysis systems (μTAS),
miniaturized CE platforms have received more and more attention. This is because CE
has two distinct advantages in terms of miniaturization. The first is that the
electroosmotic flow (EOF) in CE can serve as a pumping system. Injection and
transportation of analytes in CE can be controlled easily by adjusting electrical potentials,
which makes external valves or pumps unnecessary. The second advantage is that in CE,
band broadening is caused only by longitudinal diffusion. This makes CE separation
efficiency dependent on the magnitude of voltage applied; thus, in a very short capillary,
high efficiency can still be achieved.
However, for polymeric microchip CE devices, protein adsorption and unstable EOF are
two major barriers that limit the application of polymer devices in protein analysis. As
discussed in Section 1.2.5, dynamic coating and permanent surface modification are two
effective methods that are used to improve CE performance in polymeric microdevices
for protein analysis. Dynamic coating is simple and fast, but its effects do not last long
(i.e., it is a temporary surface modification method); permanent surface modification is
often complex and labor intensive, but it is more effective. Here I report my protein
analysis research using both untreated and surface-modified poly(methyl methacrylate)
(PMMA) microdevices. These results indicate that poly(ethylene glycol) (PEG) grafting
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for surface modification is an effective method to improve the performance of polymeric
microdevices in protein analysis.

3.2 Experimental Section
3.2.1 Materials
Hydroxypropyl cellulose (HPC), 2-bromoisobutyryl bromide (98%), poly(ethylene
glycol) methyl ether methacrylate (PEGMEMA, MW ~475), 2,2'-dipyridyl (99+%),
copper(I) chloride (98+%), and copper(II) bromide (99%) were purchased from Aldrich
(Milwaukee, WI). Heptane, tetrahydrofuran, absolute methanol, urea and pyridine (all
reagent grade), trypsin (molecular biology grade) and dithiothreitol (molecular biology
grade) were obtained from Fisher Scientific (Fair Lawn, NJ). Fluorescein isothiocyanate
(FITC), bovine serum albumin (BSA), trypsinogen, FITC-labeled BSA (FITC-BSA) and
FITC-labeled insulin (FITC-insulin) were purchased from Sigma (St. Louis, MO). Rphycoerythrin (PE) and recombinant, enhanced green fluorescent protein (GFP) were
purchased from Polysciences (Warrington, PA) and Clontech (Palo Alto, CA),
respectively. Phosphorylated phosducin-like protein (p-PhLP) was a gift from Dr. Craig
Thulin in the Department of Chemistry and Biochemistry at Brigham Young University.
Deionized water was from an EasyPURE UV/UF purification system (Barnstead,
Dubuque, IA), and the buffer solution used for CE experiments was 10 mM Trizma
hydrochloride (Tris) at pH 8.7, which was filtered using 0.2-µm syringe filters (Pall
Gelman Laboratory, Ann Arbor, MI).
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3.2.2 Microfluidic Device Fabrication
The fabrication of PMMA (Plaskolite, Columbus, OH) microchips was adapted from
protocols described previously [14]. First, an 800 nm thick silicon dioxide layer was
grown on 4-inch silicon wafers (Encompass Distribution Services, Pleasanton, CA) at
1100 ºC using a tube furnace with oxygen and water purging (Figure 3.1a). Then, 1 μm
thick Shipley 812 positive photoresist (Shipley, Marlborough, MA) was spin coated on an
oxidized silicon wafer at 3500 rpm for 120 s, followed by soft baking at 90 ºC for 2 min
to increase adhesion and photoresist stability (Figure 3.1b). Photoresist-coated silicon
wafers were covered with a photomask and exposed to UV radiation for 40 s using a
PLA-501F (Canon, Tokyo, Japan) contact mask aligner. The photomask was designed
using Clewin (WieWeb Software) and transferred to a chrome/glass wafer using a pattern
generator. After UV exposure, photoresist was developed with Microposit 351 developer
(20% aqueous solution, Shipley) for 30 s, followed by hard baking in an oven for 30 min
at 150 ºC (Figure 3.1c). Next, the silicon template was immersed into buffered oxide
etchant for 15 min to remove silicon dioxide which was not covered by photoresist
patterns (Figure 3.1d). Then, the silicon wafer was etched to give the final template using
40% aqueous KOH solution for 40 min at 80 ºC, which gave ~30 μm tall protruding
features (Figure 3.1e). A hot embossing method was used to transfer channel features
from the etched silicon template to 1.5-mm-thick PMMA substrates in an oven at 120 ºC
(Figure 3.1f-g) [14]. Thermal bonding at 95 ºC was used to seal the patterned PMMA
substrates to a blank PMMA cover plate (Figure 3.1h-i). For PEG-grafted PMMA
microdevices, thermal bonding was conducted after PEG surface modification had been
performed.
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Figure 3.1 Fabrication of PMMA microdevices. Additional details are given in the
text.
The dimensions of the PMMA microdevices are shown in Figure 3.2. After imprinting,
the microchannels in PMMA are trapezoidal, and have a top width of 115 μm and a
bottom width of 49 μm. The depth of the channels is 32 μm. Each short arm of a T
section is 0.5 cm long, and the whole length of the separation channel (including one arm
of a T section) is 4 cm (Figure 3.2b) [15]. The access holes in the PMMA cover plate
were cut using a C-200 CO2 laser engraving system (Universal Laser Systems, Scottsdale,
AZ).
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Figure 3.2 (a) Channel profile and (b) picture of a PMMA microdevice.

3.2.3 Surface Modification of PMMA Microchips
The surface modification of PMMA microdevices was mostly done by Dr. Jikun Liu in
the Department of Chemistry and Biochemistry at Brigham Young Univeristy [15]. The
scheme for surface modification is shown in Figure 3.3. Briefly, the PMMA surface was
first activated (oxidized) to give hydroxyl groups using an oxygen plasma generated by a
DEM-451 reactive ion etcher (Anelva, Tokyo, Japan). Then, a typical ATRP initiator, 2bromoisobutyryl bromide, was immobilized on the PMMA channel surface under a
water-free environment. Finally, PEG grafting solution containing CuCl, CuBr2, 2,2’dipyridyl, PEGMEMA, and DI water was used to graft a thin film of poly(PEGMEMA)
on the PMMA surface.
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Figure 3.3 PEG grafting on a PMMA surface using ATRP.

3.2.4 Trypsin Digestion of Proteins
The tryptic digestion of BSA was performed following a protocol described in the
literature [13]. First, 1 mg of BSA was dissolved in 300 μL of 20 mM Tris buffer (pH 8.7,
with 6 M urea). Next, the BSA sample was reduced by dithiothreitol for 1 h, followed by
iodoacetamide alkylation for 1 h. Then, trypsin was added to the pretreated BSA sample
at the mass ratio of 1:50 (trypsin/BSA). The resulting solution was put in a water bath at
37 ºC and then allowed to react overnight. After the trypsin digestion was done, the BSA
digest was desalted using a cellulose ester dialysis membrane with a MWCO of 100 for
24 h. FITC (6 mM) in acetone (10:1 FITC/BSA molar ratio) was used to label the BSA
tryptic digest fluorescently. The reaction was run for at least 24 h in the dark at room
temperature; longer reaction times (up to 5 days) led to more complete labeling.
The decomposed trypsinogen sample I used in microchip CE was prepared by autodegradation of a trypsinogen sample. Briefly, trypsinogen was dissolved in Tris buffer
(pH 8.7) to make a 2 mg/mL solution. Then an appropriate volume of 6 mM FITC
solution was added to the protein solution to make a 5:1 molar ratio of FITC to protein.
The labeling and auto-degradation reactions were performed in the dark for 2 weeks,
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which finished the degradation reaction and hydrolyzed unreacted FITC. The autodegradation reaction could happen because no trypsin/trypsinogen inhibitor was added to
the mixture.
3.2.5 FITC Labeling of Proteins
The protocols for tagging of proteins with FITC were adapted from previous work [1416]. Briefly, proteins were dissolved in Tris buffer (pH 8.7) to make a 2 mg/mL solution.
An appropriate volume of 6 mM FITC solution was added to the protein solution to make
a 5:2 molar ratio of FITC to protein. The reaction time was the same as for FITC labeling
of tryptic digests.
3.2.6 Protein Adsorption Tests
To study the protein adsorption in both untreated and PEG-grafted PMMA channels, I
flushed FITC-labeled BSA through PMMA microdevices at 2 µL/min [15]. After 30 min,
20 mM Tris buffer was used to wash out unbound protein for 1 h at 10 µL/min. Then, the
microchip was placed on a microscope stage, and a ~400 μm diameter region of the
device was illuminated with 488 nm laser light. Fluorescence images were recorded with
a Nikon Coolpix digital camera [17].
3.2.7 Separation and Detection of Peptides and Proteins
My microchip CE and laser-induced fluorescence detection methods have been described
previously [14, 15]. For these experiments, the injection voltage was 0.8 kV, the
separation voltage was 2.0 kV, and the data sampling frequency was 100 Hz. For
untreated and PEG-grafted PMMA microchips, Tris buffer (pH 8.7) was used. To
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perform CE in dynamically coated PMMA microchips, HPC was dissolved in Tris buffer
(pH 8.7) to make a 0.5% w/v solution.

3.3 Results and Discussion
3.3.1 Methods to Improve Protein Separation Performance
Polymers represent the second generation of materials to be employed in microdevice
fabrication. Compared to inorganic materials, polymer microdevices are easy to fabricate
and relatively cheap. However, when applying polymeric microdevices in bioanalytical
separations, unstable EOF and nonspecific adsorption are two major barriers. To solve
these problems, dynamic coating and permanent surface modification are two possible
solutions. I used both dynamic coating with HPC in untreated PMMA microdevices and
grafting of a thin film of PEG on the PMMA channel surface using ATRP to improve
microchip performance. Protein and peptide separations were compared in these modified
and untreated PMMA microdevices to evaluate their efficiency.
3.3.2 Protein Adsorption Studies
When applying polymer microdevices in protein analysis, adsorption is a big concern;
indeed, native PMMA has some nonspecific adsorption. Dynamic coating (e.g., with
HPC) can reduce protein adsorption temporarily, but this reduction is not reproducible
and the effect is reversible. To permanently eliminate nonspecific adsorption, ATRP
surface modification is a superior choice. I carried out BSA adsorption experiments, as
shown in Figure 3.4. I noticed much greater BSA adsorption (green area) on untreated
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PMMA channel surfaces, compared to PEG-grafted PMMA, indicating that the ATRP
process significantly reduced surface protein adsorption.

Figure 3.4 Fluorescence micrographs of adsorbed FITC-BSA in (a) native and (b)
PEG-grafted devices.

3.3.3 Electrophoresis of Proteins in PMMA Microdevices
Figure 3.5 shows different protein separations in untreated PMMA microchips. GFP and
PE eluted as sharp peaks in PMMA microdevices dynamically coated with HPC (Figure
3.5a-b). These results indicate that untreated PMMA microdevices can be used in protein
analysis. As shown in Figure 3.5a, three GFP variants were found in CE of the GFP
sample, while only one GFP peak was observed in uncoated PMMA microdevices
(Figure 3.5c). This indicates that dynamically coated PMMA microdevices had better
resolving power than no-HPC-added, untreated PMMA microchips. I used HPC dynamic
coating to improve protein separation reproducibility in untreated PMMA microdevices.
The number of theoretical plates for the GFP peak in Figure 3.5c is 5.1×103 over a 3.5 cm
long separation channel. Importantly, the separations of protein mixtures in untreated or
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HPC-treated PMMA microdevices (e.g., Figure 3.5) were not very reproducible. I believe
this is due to unstable EOF and analyte adsorption on the channel walls.

Figure 3.5 Microchip CE of GFP and PE in (a-b) HPC-treated and (c) untreated
PMMA microchips. Microchip CE of (a) GFP, (b) PE and (c) GFP and PE. Results
were obtained from different PMMA microdevices.
Although HPC dynamic coating improves protein analysis reproducibility in PMMA
microdevices, allowing simple protein mixture separations, unmodified PMMA
microdevices are not suitable for profiling all proteins. As shown in Figure 3.6a, FITCBSA could not be separated efficiently in untreated PMMA microdevices. The poor CE
performance for FITC-BSA in untreated PMMA microdevices was probably due to
unstable EOF and nonspecific adsorption (e.g., interaction between BSA and PMMA).
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The number of theoretical plates for the highest peak in Figure 3.6a is 2.7 × 103 over a
3.5 cm separation channel. In contrast, analysis of FITC-BSA in a PEG-grafted PMMA
microchip (Figure 3.6b) showed much sharper peaks (2.2 × 104 plates) and shorter
separation time, as the PEG coating stabilized EOF and decreased analyte adsorption.

Figure 3.6 Microchip CE of FITC-BSA in (a) untreated and (b) PEG-grafted
PMMA microdevices.
Figure 3.7 shows the reproducibility of FITC-BSA CE separations in a PEG-grafted
PMMA microdevice. Compared to FITC-BSA separations in untreated PMMA
microchips, PEG-grafted PMMA microdevices have much better reproducibility. The
relative standard deviation for the largest BSA peak in Figure 3.7 is 1.3% over 10 runs,
and more than 20 sequential BSA separations could be achieved reproducibly in PEG-
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grafted PMMA microdevices. In addition, the lifetime for good CE separations in PEGgrafted PMMA micrchips was >200 runs, which indicates that the grafted PEG layer is
very robust.

Figure 3.7 Reproducibility of microchip CE of FITC-BSA in a PEG-grafted PMMA
microdevice.
I also performed protein mixture separations in PEG-grafted PMMA microdevices. As
shown in Figure 3.8, a protein mixture containing BSA, PE and GFP was well resolved in
a PEG-grafted PMMA microdevice. At least 6 peaks (1 from PE; 2 from GFP and 3 from
BSA) were resolved. The relative standard deviation of the migration time for the last
GFP peak was 0.81% over 4 runs, which indicates that PEG-grafted PMMA
microdevices are capable of separating protein samples reproducibly.

93

Figure 3.8 Microchip CE of a protein mixture.

3.3.4 Peptide Separations in PMMA Microchips
Peptide separation is another important application of microchip CE. Figure 3.9 shows
CE of FITC-insulin in a PEG-grafted microdevice. Seven peaks were identified in the
separation, while conventional CE only gave one peak (data not shown). Tricine peptide
gel electrophoresis indicated that this FITC-insulin sample had multiple components
(data not shown). As many as 2.8×104 theoretical plates were obtained for the largest
peak in Figure 3.9 with a 3.5 cm long separation channel. The relative standard deviation
for this peak’s migration time was 0.6% over 5 runs. These results indicate that PEGgrafted PMMA microdevices have high performance in peptide separation.
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Figure 3.9 Microchip CE of impure FITC-insulin in a PEG-grafted microdevice.
Phosphorylation of proteins is important to their function. To determine the
phosphorylation site of a protein, the current protocol includes two steps. The first step is
to digest the protein with trypsin (or another enzyme); the second step is to identify the
resulting peptide fragments using liquid chromatography (LC) and mass spectrometry
[18]. In this protocol, effective separation of the tryptic digest is key. Besides LC,
microchip CE is another possible candidate to fractionate tryptic digests, because of rapid
analysis and low sample consumption. Figure 3.10 shows microchip CE of a decomposed
trypsinogen sample in a dynamically coated PMMA microdevice. At least 15 peptide
fragments could be identified in the electropherogram. This result indicates that PMMA
microchips have potential to be employed in tryptic digest separations.
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Figure 3.10 Separation of a decomposed trypsinogen sample in an HPC-coated
PMMA device.
However, the reproducibility of the tryptic digest separation in untreated PMMA was less
than desired. As discussed in the Section 3.3.3, analytes adsorption and unstable EOF are
two major reasons. Thus, I also tried microchip CE of a BSA tryptic digest in a PEGgrafted PMMA microdevice (Figure 3.11). The tryptic digest was successfully resolved,
and the separations were reproducible with a migration time relative standard deviation of
0.56% over 4 runs for the last peak.
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Figure 3.11 Microchip CE of a BSA tryptic digest.
To test a biological application of PEG-grafted PMMA microdevices, I evaluated the CE
separation performance of a tryptic digest of phosphorylated PhLP. PhLP is a homologue
of phosducin, a known major regulator of Gβγ signaling in the retina and pineal gland;
however, as yet, the function of the PhLP remains unclear [19]. One important function
of PhLP is that it binds directly to Gβγ in vitro, and phosphorylation of PhLP (to form pPhLP) is important to its function. However, the mechanism of phosphorylation is not yet
known. I used microchip CE to separate a tryptic digest of p-PhLP in a PEG-grafted
PMMA microdevice, and the result is shown in Figure 3.12a. Theoretically there should
be more than 30 peptide fragments produced when p-PhLP is digested using trypsin; but
limitations in the FITC chemistry make it such that not all peptide fragments are well
labeled. In microchip CE of p-PhLP, at least 6 peptide fragments were identified, which
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was also corroborated by a tricine peptide gel (Figure 3.12b). Importantly, this result
indicates that PEG-grafted PMMA microdevices are suitable for real biological sample
analysis.

Figure 3.12 Comparison of p-PhLP digest separation in (a) microchip CE and (b)
tricine peptide gel.

3.4 Conclusion
Microchip CE of proteins and peptides in PMMA microdevices has been evaluated in this
chapter. The results indicate that ATRP grafting of PEG offers superior results to
dynamic coating for biological separations in PMMA microdevices. I believe that PMMA
microdevices should be broadly applicable in biomolecular analysis.
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Chapter 4. In-Channel Atom-Transfer Radical Polymerization
of Thermoset Polyester Microfluidic Devices for Bioanalytical
Applications*
4.1 Introduction
Polymeric materials have become a common choice in the field of microfluidics [1], with
an increasing number of microdevices being fabricated using polymers instead of glass
[2, 3], as in earlier research. In addition to the general advantages of microfluidic devices
for chemical analyses – reduced sample consumption, potential for integration of various
operations, fast analysis times, multiplexing for high throughput, and portability –
polymer microchips can reduce costs, making disposable devices more practical. Also,
the polymers available for use offer a variety of inherent material properties to choose
from (e.g., reversible sealing, resistance to selected solvents, etc.), and the associated
fabrication techniques tend to be more flexible, in terms of making multilayer fluidic
designs, and limiting the need for highly specialized equipment.
Common hard polymers used for the fabrication of microfluidic devices – including
poly(methyl methacrylate) (PMMA) [4, 5], poly(carbonate) [6], cyclic olefin copolymer
[7] and poly(ethylene terephthalate) [1] – are fabricated via the plastic machining
techniques of embossing, injection molding, or laser ablation. The popular
poly(dimethylsiloxane) (PDMS) [8, 9], a silicone elastomer that is microfabricated via
replica molding, has been used widely in microfluidics research due to the speed and ease
with which new fluidic designs can be created and then formed into devices, as well as
* This chapter is reproduced with permission from Electrophoresis 2007, (In Press). Copyright 2007 Wiley
-VCH.
101

the capability of fabricating complex three-dimensional assemblies and multilayer
channel networks [10-12].
While the use of PDMS remains popular for certain applications, some undesirable
characteristics, such as surface instability [9] and incompatibility with most nonpolar
solvents [13], have established a need for analogous materials that address these issues.
One such polymer is thermoset polyester (TPE), which has been introduced previously
for the fabrication of microfluidic devices [14, 15]. Importantly, TPE microchips
combine the benefits of rapid and easy fabrication along with several desirable
characteristics in common with glass. Indeed, TPE can be shaped by a replica molding
process similar to PDMS, allowing for rapid prototyping of fluidic designs, but TPE also
exhibits surface stability and solvent resistance similar to glass. Also of note, TPE is not
elastomeric like PDMS; it is a rigid material.
For bioanalysis applications, the surfaces of materials, whether glass or polymeric, are
often modified to increase separation efficiency and reproducibility, since biological
molecules often interact with surfaces, causing sample loss and peak broadening. Surface
modification in both capillary electrophoresis (CE) and microchip CE is common, and a
variety of techniques are available, including dynamic surface coating [16] and many
forms of chemical modification [17, 18]. Atom-transfer radical polymerization (ATRP)
[19-21] has been used for chemical derivatization of PDMS [22, 23] and PMMA [5]
microchannels. ATRP modification of plastics involves activation of the surface via
plasma oxidation, immobilization of the initiator, and subsequent grafting of the chosen
polymer to the surface. In ATRP, the length of polymer tethered to the surface can be
controlled readily. ATRP has been used to attach various polymers, including
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polyacrylamide [24], hydroxypropyl cellulose [25], methacrylate [26], poly(ethylene
glycol) (PEG) [5], and peptidoglycans [27]. Typically, neutral polymers are used to
eliminate the possibility of electrostatic interactions with analytes. PEG-modified PMMA
devices have shown increased separation performance relative to unmodified microchips
[5], so I was interested in applying this surface derivatization approach to different
polymers.
Here, I present a new approach for in-channel ATRP grafting of a thin film of PEG on the
surface of TPE microchannels. These modified TPE microdevices had reduced
nonspecific analyte adsorption, and lower and more pH-stable electroosmotic flow
(EOF). I have tested these PEG-grafted TPE microchips in CE analysis of amino acids
and peptides. I have further demonstrated their utility in probing the phosphorylation
efficiency for a model protein.

4.2 Experimental Section
4.2.1 Materials
2-Bromoisobutyryl bromide (98%), poly(ethylene glycol) methyl ether methacrylate
(PEGMEMA, MW ~475), 2,2'-dipyridyl (99+%), copper(I) chloride (98+%), and
copper(II) bromide (99%) were purchased from Aldrich (Milwaukee, WI) and used
without further purification. Heptane, tetrahydrofuran, absolute methanol, and pyridine
(all reagent grade) were obtained from Fisher Scientific (Fair Lawn, NJ). Fluorescein
isothiocyanate (FITC), aspartic acid, glycine, asparagine, Phe-Ala (FA), Phe-Gly-GlyPhe (FGGF) and angiotensin 1 were purchased from Sigma (St. Louis, MO). Phosducinlike protein (PhLP) and phosphorylated PhLP (p-PhLP) were gifts from Dr. Craig Thulin
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in the Department of Chemistry and Biochemistry at Brigham Young University. PhLP
has a molecular weight of ~33 kDa and pI of ~4.7 [28, 29]. Deionized water was from an
EasyPURE UV/UF purification system (Barnstead, Dubuque, IA), and the buffer solution
for CE experiments was 10 mM Trizma hydrochloride (Tris) at pH 8.7, which was
filtered using 0.2-µm syringe filters (Pall Gelman Laboratory, Ann Arbor, MI).
4.2.2 Microfluidic Device Fabrication
Figure 4.1 is a schematic of the TPE microdevice fabrication procedure. TPE microchips
were constructed similarly to the protocol described previously [15], with a modified
pretreatment of the masters. SU-8 patterned silicon masters were prepared using
photolithography as described elsewhere [1]. In short, SU-8 50 (Microchem, Newton,
MA) negative photoresist was spin-coated onto 3-in. silicon wafers (Montco Silicon
Technologies, Royersford, PA) to a thickness of 50 μm. A phototransparency with a
printed design of a double-T microchannel with a pattern width of 50 μm was used as the
lithography mask. Following exposure, the wafers were baked and developed with
propylene glycol methyl ether acetate (Sigma-Aldrich, Milwaukee, WI), yielding a SU-8
patterned silicon master (Figure 4.1a). Instead of sputter coating the master with SnO2 as
before [1], in this work the SU-8 patterned silicon masters were treated by reaction with
hexamethyldisilazane (HMDS, Sigma-Aldrich) prior to replica molding with TPE;
masters and a minimal amount of HMDS were placed in a loosely covered container in a
60 ºC oven overnight. The microchannels were designed to be 50 μm wide by ~50 μm
tall, and the offset spacing of the injection arms was 50 μm. Each arm of the double-T
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section was 0.5 cm long, and the separation channel was 3 cm long. Circular areas for
reservoirs were 5 mm in diameter (Figure 4.1).

(a)

(b)

(c)

(d)

(e)

Figure 4.1 Schematic of the procedure for the fabrication of TPE microfluidic
devices. (a) A SU-8 patterned silicon master is treated with HMDS vapor. (b) A
PDMS mold enclosure and posts are placed on the master. (c) TPE resin containing
UV photoinitiator and catalyst is poured into the master assembly; transparency
film is used on the top. (d) Following exposure to UV radiation, the semicured TPE
replicas are removed from the master, and (e) brought into contact. Additional UV
exposure and heat are used to completely cure the TPE chip.
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TPE was prepared by mixing the resin (Polylite 32030-10, Reichhold, Research Triangle,
NC) with additional cross-linker (styrene, Sigma-Aldrich), UV photoinitiator (2,2dimethoxyphenylacetophenone, Irgacure 651, Sigma-Aldrich), and methyl ethyl ketone
peroxide (MEKP) catalyst (Crompton, Greenwich, CT). Approximately 0.10 g of the
photoinitiator were dissolved in 0.25 g of styrene monomer and then added to 10 g of
resin. Three drops of MEKP catalyst (~0.09 g) were added to the resin/styrene mixture,
which was stirred and degassed to remove air bubbles. After degassing, the TPE mix was
poured onto the patterned master. Cylindrical PDMS (Sylgard 184, Dow Corning,
Midland, MI) posts were placed on the master to define access holes. In addition, a piece
of PDMS was cut to form a mold enclosure, which was conformally sealed to the master
to contain the resin in the desired region (Figure 4.1b). A piece of transparency film
(3M), cut to an appropriate size, was used as a top cover over the resin to ensure a flat
surface (Figure 4.1c).
The cast TPE resin was exposed to radiation using a custom-built UV exposure box,
which contained two long-wave UV bulbs with peak intensity at 365 nm (TLK 40W/10R,
Philips). Samples were placed ~15 cm from the sources. TPE pieces (one patterned and
one flat) were exposed for 3 min and peeled away from the masters (Figure 4.1d). The
patterned substrate was brought into contact with the flat piece to form an enclosed chip
(Figure 4.1e), which was then exposed to UV light for an additional 2 min using four
periods of 30-s exposures with 1.5-min intervals between exposures. Following UV
curing, the TPE pieces were heated to 60 ºC for 30 min and 120 ºC for 1.5 h before
finally cooling to room temperature.
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4.2.3 ATRP Surface Modification of TPE Microdevices
Immobilization of Initiator. The method of in-channel ATRP used here (Figure 4.2) is
similar to previously reported work [5]. A typical ATRP initiator, 2-bromoisobutyryl
bromide, was immobilized on the channel surfaces of the TPE microdevice under a
water-free environment. The immobilization solution was prepared by dissolving 2bromoisobutyryl bromide (5 mM) and pyridine (5.5 mM) in a heptane/THF solution.
Then the solution was pumped through the TPE microchannels at 2 μL/min using a
syringe pump. After 6 h, heptane was rinsed through the microchannels to stop the
initiator immobilization reaction. Lastly, vacuum was applied to dry the microchannels.

Figure 4.2 Scheme for in-channel ATRP surface modification.
In-channel Grafting of PEG on TPE surfaces. The preparation of the PEG grafting
solution and the assembly of the syringe and TPE microdevice were carried out in a glove
box. First, CuCl (0.0424 g), CuBr2 (0.0287 g), 2,2’-dipyridyl (0.174 g), 4 mL of
PEGMEMA, and 6 mL of DI water were mixed in the glove box for 15 min. 1 mL of this
solution was transferred to a new container, and 9 mL of DI water was added to make the
final diluted grafting solution. The syringe was filled with diluted grafting solution, and
the fittings and TPE microdevice were assembled in the glove box and taken out. The
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grafting solution was pumped through the TPE microchannels at 2 μL/min for 6 h to
accomplish ATRP grafting, and then DI water was used to flush the microchannels.
4.2.4 X-ray Photoelectron Spectroscopy (XPS) and Contact Angle Measurements
A SSX-100 X-ray photoelectron spectrometer (Service Physics, Bend, OR) with a
monochromatic Al Kα source and a hemispherical analyzer was used to investigate the
TPE surfaces before and after ATRP modification. The investigations were carried out
similar to

previous work [15]. For the contact angle measurements, a NRL-100

goniometer (Ramé-Hart, Mountain Lakes, NJ) was used after 4 μL of DI water was
placed on the surface with a syringe.
4.2.5 EOF Measurements
EOF measurements in TPE microdevices were done as I have reported previously [5],
using the current monitoring method [30]. The EOF rates in TPE microdevices were
measured at five different pH values. The buffers (all 30 mM) included 4morpholineethanesulfonic

acid

(pH

6),

N-[Tris(hydroxymethyl)methyl]-2-

aminoethanesulfonic acid (pH 7), Tris (pH 8), phosphate buffered saline (pH 9) and 3(cyclohexylamino)-1-propane sulfonic acid (pH 10); the ionic strength of these buffers
was adjusted to 30 mM with NaCl. For a typical EOF measurement, the TPE
microchannels were rinsed with DI water thoroughly, followed by buffer. Before
measurement, one reservoir was emptied, and a lower concentration (1.5 mM) of the
same buffer was introduced into that reservoir. The high voltage used in EOF
measurements was provided by a PS-350 high voltage supply unit (Stanford Research
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Systems, Sunnyvale, CA). The channel current signal was transferred to a computer
through a PCI-1200 data acquisition board (National Instruments, Austin, TX), and was
recorded using LabView 8i (National Instruments). For each pH point, three
measurements were performed, and error bars represent ±1 standard deviation.
4.2.6 FITC Labeling of Amino Acids, Peptides and Proteins
The protocols for labeling amino acids, peptides and proteins with FITC were adapted
from previous work [5, 31, 32]. Briefly, each analyte was dissolved individually in
filtered 10 mM carbonate buffer (pH 9.2). FITC was dissolved in absolute dimethyl
sulfoxide to make a 6 mM solution. For amino acids, 600 μL of each 3 mM amino acid
solution was mixed thoroughly with 200 μL of 6 mM FITC solution. For peptides, 50 μL
of 6 mM FITC solution was added to 200 μL of a 2 mM solution of each individual
peptide. The FITC labeling reaction was run for at least 24 h in the dark at room
temperature; longer reaction times (up to 5 days) led to more complete labeling and
elimination of the unreacted FITC peak.
For FITC labeling of PhLP and p-PhLP, the proteins were desalted and concentrated
individually using Microsep 3K Omega centrifuge tubes (Pall, East Hills, NY), which
have a molecular weight cutoff of 3000. The solution in the upper chamber of the tube
was diluted with carbonate buffer (pH 9.2) to make a ~2 mg/mL protein solution. An
appropriate volume of 6 mM FITC solution was added to this protein solution to make a
5:2 molar ratio of FITC to protein. The reaction time was the same as for FITC labeling
of amino acids and peptides.

109

4.2.7 Protein Adsorption Tests
To study the protein adsorption in both untreated and PEG-grafted TPE channels, I
flushed FITC-labeled bovine serum albumin (BSA) through TPE microdevices at 2
μL/min [5]. After 30 min, 20 mM Tris buffer was used to wash out unbound protein for 1
h at 10 μL/min. Then, the microchip was placed on the microscope stage and a ~400-μmdiameter region of the channel was illuminated with 488 nm laser light. Fluorescence
images were recorded with a Nikon Coolpix digital camera and analyzed using Digital
V++ software (Digital Optics Limited, Auckland, New Zealand) as in earlier work [33].
4.2.8 Separation and Detection of Amino Acids, Peptides and Proteins
The microchip CE and laser-induced fluorescence detection methods have been described
previously [5, 32]. For these experiments, the injection voltage was 0.8 kV, the separation
voltage was 2.0 kV, and the data sampling frequency was 100 Hz.

4.3 Results and Discussion
4.3.1 Surface Modification
The cross-linkage bonding of TPE devices is one of the advantages of this fabrication
method. However, the previous ATRP procedures for unbonded PMMA surfaces [5]
would interfere with the cross-linking process. Thus, I developed an in-channel ATRP
modification approach. The ATRP process is typically carried in still (i.e., not flowing)
solution, particularly for PEG grafting, which could cause problems for microchannel
surface modification [22, 34]. I hypothesized that if the reaction solution was flushed
through microchannels at a sufficiently slow flow rate, the reaction conditions would be

110

close enough to “still” to allow ATRP functionalization. The method I report here, inchannel ATRP, uses slow flow of low-concentration reactant to carry out ATRP reactions
inside the TPE channels. Importantly, since in-channel ATRP is done after the TPE
microdevices have been bonded together, it does not interfere with device fabrication.
In the ATRP grafting of PMMA microdevices, the first step is plasma activation to form
surface hydroxyl groups [5]. I expected TPE to have sufficient surface hydroxyl groups
that I could omit the plasma oxidation step. Indeed, I obtained similar results with ATRP
reactions on both plasma-activated and native TPE surfaces, so I skipped the plasma
oxidation procedure in subsequent experiments. The second step for in-channel ATRP is
the immobilization of initiator (2-bromoisobutyryl bromide) on the TPE channel surface.
In this work, I used heptane/THF (v/v 4:1) as the solvent, since this mixture does not
dissolve or swell TPE at room temperature. It was critical to optimize the concentrations
of 2-bromoisobutyryl bromide and pyridine, because I found under some conditions that
this reaction produced precipitates that could block the channels. The best results were
obtained with 5 mM 2-bromoisobutyryl bromide and 5.5 mM pyridine in a heptane/THF
solution. This mixture provided a uniform layer of initiator grafted on the TPE surface
without blocking the channels. I also adjusted the PEG grafting solution composition and
settled on a mixture that contained ten-fold lower PEG and catalyst concentrations
compared to the earlier PMMA studies [5].
4.3.2 XPS and Contact Angle Measurements
XPS was used to determine the elemental composition of the TPE surfaces before and
after modification, and the results are shown in Table 4.1. The XPS data indicate that the
native TPE surface was composed of 75% carbon and 25% oxygen. After in-channel
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ATRP, the elemental composition changed to 69% carbon and 31% oxygen, reflecting
increased oxygen content due to PEG grafting. To obtain more detailed information about
the elemental composition of the TPE surface, I took high-resolution scans of the C1s
binding energy, in a similar manner to prior studies [15]. After in-channel ATRP, the
hydrocarbon (C-H) surface content decreased from 61% to 29%, the ester/acid (carboxyl)
surface content decreased from 15% to 5%, and the ether/alcohol (C-O) surface content
greatly increased from 24% to 66%.

Table 4.1 XPS investigation of in-channel ATRP surface modification of TPE.
Intact TPE
TPE surface after TPE surface
surface
plasma treatment
after ATRP
C (%)
75
67
69
-carboxyl (%)
15
23
5
-C-O (%)
24
27
66
-C-H, C-C (%)
61
51
29
O (%)
25
33
31
Water contact angles for both PEG-grafted and native TPE were obtained. The contact
angle for the PEG-grafted TPE surface was 43º, while native TPE had a contact angle of
61º. Both results agree well with previous reports of the contact angles of PEG-grafted
PMMA [5] and native TPE [15]. The change in the contact angle before and after surface
modification indicates that the chemistry and hydrophilicity of the TPE surface were
altered through ATRP treatment, which is also consistent with the XPS investigation.
4.3.3 EOF Measurements
In PEG-grafted TPE microchips, the EOF goes from anode to cathode, which is similar to
what I observed in untreated TPE devices. Figure 4.3 shows EOF measurements in both
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PEG-grafted and untreated TPE microchannels for different pH values. Compared to the
pH-variant EOF in untreated TPE microchannels, PEG-grafted TPE has very stable EOF
(~1.0×10-5 cm2s-1V-1) in a wide pH range (6 – 10), which should help in highperformance biomolecule analysis. Also, the EOF values in PEG-grafted TPE channels
are 5-10 times lower than the corresponding measurements in untreated ones.

Figure 4.3 EOF measurements in untreated TPE microchannels (diamonds) and inchannel PEG-grafted TPE microchannels (squares). For some data points, error
bars may be covered within the data points.
4.3.4 Protein Adsorption Studies
Although polymer microdevices are easy to fabricate and relatively cheap, they are not
inherently the best choice for some bioanalytical applications. In untreated TPE devices,
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protein adsorption and unstable EOF are two major barriers that would limit the use of
these microdevices. However, after ATRP modification, the PEG-grafted TPE surface is
expected to have reduced protein adsorption compared to untreated devices. To test this, I
carried out BSA adsorption experiments, as shown in Figure 4.4. I noticed much greater
BSA adsorption on the untreated TPE channel surfaces, compared to PEG-grafted TPE
channels, indicating that the ATRP process significantly reduces protein adsorption on
the surface.

Figure 4.4 FITC-BSA adsorption tests on TPE chips before (upper, offset) and after
(lower) in-channel ATRP PEG grafting. The dashed lines define the channel
borders.
4.3.5 Electrophoresis of Amino Acids, Peptides and Proteins
Figure 4.5 shows CE results for the separation of amino acid and peptide mixtures. Both
the amino acid and peptide mixtures were well resolved using PEG-grafted TPE
microdevices. The glycine peak in Figure 4.5a was used to evaluate the CE performance
of TPE microdevices, and 4.5 × 103 plates for a 3.0-cm-long separation channel were
obtained. Moreover, the relative standard deviation for the glycine migration time over 4
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runs was 2.1%. In addition to amino acid analysis, PEG-grafted TPE microdevices offer
good performance in peptide separation. The number of theoretical plates for the FGGF
peak in Figure 4.5b was 1.2 × 103, and the relative standard deviation for the FGGF
migration time in 4 runs was 4.4%. The number of theoretical plates for amino acid
separations in PEG-grafted TPE microdevices is similar to uncoated glass [3], TPE [15],
PMMA [32] and PDMS [9] without buffer additives, but the PEG-grafted TPE
microdevices could provide much more rapid amino acid separations. The performance
of PEG-grafted microdevices may be worse than that of surface-derivatized glass
microdevices, but glass chips are much harder to make. Moreover, CE separations in the
PEG-grafted TPE microdevices were reproducible. The lifetime for good CE separations
in a PEG-grafted TPE micrdevice is at least 50 runs, which indicates that the grafted PEG
layer is very robust. These results indicate that in-channel ATRP is an effective surface
modification method for TPE microdevices, leading to reduced EOF and reproducible
separations.
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Figure 4.5 Microchip CE separation of FITC-tagged (a) amino acids and (b)
peptides. The concentrations of peptides and amino acids tested in CE were all 50
μM.
To evaluate a biological application of PEG-grafted TPE microdevices, I developed a
simple experiment to test the phosphorylation efficiency of PhLP. A widely expressed
ethanol-responsive gene, PhLP, is a homologue of phosducin, a known major regulator of
Gβγ signaling in the retina and pineal gland; however, as yet, the function of the PhLP
remains unclear [35]. PhLP directly binds Gβγ in vitro, and phosphorylation of PhLP is
important to its function, but the mechanism of phosphorylation is not yet known. In
Chinese Hamster Ovary (CHO) cells, the concentration of PhLP is ~0.15 μM; but after
angiotensin II treatment, the concentration of PhLP in CHO cells can be higher than 1
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μM [36]. I have performed microchip CE of PhLP and p-PhLP mixtures, as shown in
Figure 4.6. From these results, I see that the phosphorylation efficiency is high, but a
small PhLP peak is still seen in the CE analysis of the PhLP phosphorylation mixture
(Figure 4.6b). This result has also been verified by conventional gel electrophoresis of
PhLP proteins (data not shown). The time variation between the two PhLP peaks in
Figure 4.6a-b is due to small differences in the detection position selected during each CE
experiment. The relative standard deviation for PhLP separation is 6.6% over 3 runs,
while the deviation for p-PhLP separation is 4.1% over 4 runs. Importantly, this result
indicates that PEG-grafted TPE microdevices are suitable for protein analysis work.

Figure 4.6 Microchip CE of (A) PhLP and (B) p-PhLP. The concentrations of both
proteins were ~ 1.4 μM.
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4.4 Conclusion
In-channel ATRP has been developed and applied in the surface modification of TPE
microdevices. XPS and contact angle measurements confirm the grafting of PEG to the
TPE surface. Significantly reduced EOF and nonspecific protein adsorption were
observed in PEG-grafted TPE microchannels. Rapid CE separations of amino acids,
peptides and proteins have been obtained, indicating that PEG-grafted TPE microdevices
should be broadly applicable in biomolecular analysis.
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Chapter 5. Design and Evaluation of a Coupled
Monolithic

Affinity

Electrophoresis

Column−Capillary

System

for

Cancer

Zone

Marker

Analysis
5.1 Introduction
As reviewed in Section 1.3.2, affinity methods can be useful in cancer marker analysis.
As described in Section 1.3.3, several approaches have been developed to covalently
attach antibodies on glycidyl methacrylate (GMA) monolith surfaces, but these
techniques cannot effectively control the orientation of attached antibodies. In this
chapter I report a method to attach appropriately oriented antibodies on GMA-based
monoliths to ensure high bioactivity of the antibodies. In addition, I have applied this
method to fabricate an affinity capillary electrophoresis (CE) column for human
chorionic gonadotropin (hCG) analysis.

5.2 Experimental Section
5.2.1 Materials

Dextran sulfate sodium salt, dimethyl sulfoxide (DMSO), hexadimethrin bromide
(polybrene), GMA 97%, trimethylolpropane trimethacrylate (TRIM), polyethylene glycol
diacrylate

(PEGDA),

ethylene

dimethacrylate

(EDMA),

2,2-dimethoxy-2-

phenylacetophenone (DMPA) 99%, glycine, ethylenediamine (EDA), fluorescein
isothiocyanate (FITC), bovine serum albumin (BSA), trypsin, myoglobin and β-casein
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were supplied by Sigma–Aldrich (Milwaukee, WI). Recombinant, enhanced green
fluorescent

protein (GFP)

was purchased

from Clontech (Palo

Alto,

CA).

Sulfosuccinimidyl 4-N-maleimidomethyl cyclohexane-1-carboxylate (sulfo-SMCC), 2mercaptoethylamine (2-MEA), and dextran desalting columns were obtained from Pierce
(Rockford, IL). hCG, βhCG and anti-βhCG were acquired from Calbiochem (La Jolla,
CA). Anhydrous methanol, acetone and hexanes were purchased from Mallinckrodt
Chemicals (Phillipsburg, NJ). Cyclohexanol, ammonium formate and phosphate buffered
saline (PBS) 10× solution (pH 7.4 ± 0.1) were from Fisher Scientific (Fair Lawn, NJ).
Formic acid was from Anachemia Canada (Montréal, Canada). Sodium carbonate
monohydrate and sodium bicarbonate were from EM Science (Darmstadt, Germany).
Deionized water was from an EasyPURE UV/UF system (Barnstead, Dubuque, IA).

5.2.2 Fluorescent Labeling of Proteins

For the FITC labeling of proteins, each protein was diluted with carbonate buffer (pH 9.2)
to make a ~2 mg/mL solution. An appropriate volume of 6 mM FITC in DMSO was
added to each protein solution to make a 5:2 molar ratio of FITC to protein. The FITC
labeling reaction was run for at least 24 h in the dark at room temperature.

5.2.3 Monolith Preparation in Capillaries

Fused silica capillaries with either UV-transparent or non-transparent coatings were
obtained from Polymicro Technologies (Phoenix, AZ). Prior to monolith polymerization,
capillary surfaces were treated by depositing alternating thin films of dextran and
polybrene [1]. For UV transparent capillaries, a mask blocked the UV light so only
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certain portions of the capillary had monolith polymerized. For polyimide-coated
capillaries, a UV-transparent window was created 5-7 cm from one end of the capillary.
Two kinds of monoliths were used in this project: GMA-EDMA and GMA-PEGDA. The
GMA-EDMA monomer mixture was composed of 0.006 g DMPA (initiator); 0.24 g
TRIM (cross-linker); 0.36 g GMA (monomer); and 0.72 g cyclohexanol, 0.44 g methanol
and 0.19 g hexane (porogens). The GMA-PEGDA monolith prepolymer was composed
of 0.008 g DMPA, 0.32 g PEGDA, 0.48 g GMA and 0.10 g cyclohexanol. For either
monolith, the monomer mixture was sonicated for 5 min, and was loaded into the column
by capillary action. Polymerization was performed using 320-390 nm UV radiation for 915 min. Unreacted monomer and porogens were removed by flowing methanol through
the capillaries.
5.2.4 Immobilization of Antibodies on Polymer Monoliths
The mechanism of attaching antibodies to GMA-based monoliths is shown in Figure 5.1.
The first step is to produce surface –NH2 groups. EDA was dissolved in methanol to
make a 50% solution, which was pumped through the monolith at 1 μL/min for 24 h
(Figure 5.1a). Then, a mixture of 50 mM phosphate, 0.15 M NaCl, 10 mM EDTA, (pH
7.6, PBS-EDTA) was pumped through to flush the capillary. Anti-βhCG was partially
reduced by 2-MEA to produce sulfhydryls for coupling (Figure 5.1b); 1 mg of antibody
was dissolved in 125 μL PBS-EDTA, and 12.5 μL of 60 mg/mL 2-MEA solution in PBSEDTA was added as the reducing agent. The reduction reaction was carried out at 37 ºC
for 2 h, and then the antibody was purified using a desalting column equilibrated with
PBS-EDTA buffer. Next, sulfo-SMCC was used as a crosslinker to couple partially
reduced antibodies to the amine-treated monolith (Figure 5.1c). Briefly, the sulfo-SMCC
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was dissolved in PBS-EDTA to make a 2 mg/mL solution, which was pumped through
the amine-treated monolith at 1 μL/min for 2 h. Then, purified reduced antibody solution
was pumped through the monolith for 4 h at 0.5 μL/min. Unbound antibodies were
washed out using PBS-EDTA, and the capillaries were stored at 4 ºC until use.
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Figure 5.1 Scheme for attaching antibodies on a GMA monolith.
5.2.5 Blocking Nonspecific Adsorption on the Monolith
Nonspecific adsorption on the GMA-EDMA monolith was blocked using BSA. Briefly,
1% aqueous BSA solution was flushed through the monolith for 24 h at 0.2 μL/min, and
then PBS was used to wash out unbound BSA. To study protein adsorption in both
untreated and BSA-blocked GMA-based monoliths, I flushed each test protein (FITC-
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BSA, FITC-trypsin, FITC-myoglobin, FITC-β-casein or GFP) through the monolith at
0.5 μL/min [2]. After 30 min, 20 mM Tris buffer was used to wash out unbound protein
for 2 h at 1.0 μL/min. If Tris buffer could not wash out adsorbed protein effectively, 20
mM acetate buffer (pH 4.4) was flushed for 12 h at 1.0 μL/min. After washing, the
monolithic capillary was placed on a microscope stage, and a ~400 μm length was
illuminated with 488 nm laser light. Fluorescence images were recorded with a Nikon
Coolpix digital camera and analyzed using Digital V++ software (Digital Optics Limited,
Auckland, New Zealand) as in earlier work [3].
5.2.6 Adsorption-Desorption Test of hCG in Affinity Capillaries
For initial optimization of the adsorption-desorption tests, FITC-hCG in ammonium
formate-formic acid buffer (AF-FA) was incubated on an affinity column for 1 h,
followed by PBS washing to remove unbound analyte. Then, elution buffer (formic acid
or glycine buffer) was injected into the affinity column using a syringe pump and
incubated for 5-15 min, and any desorbed hCG was washed out. Finally, the affinity
column was analyzed by fluorescence microscopy to observe protein adsorption as
described in Section 5.2.5.
For quantitative adsorption-desorption testing of hCG in affinity capillaries, a 0.2 mg/mL
hCG solution was prepared by dissolving hCG in 50 mM AF-FA buffer, pH 7.6. The hCG
sample was introduced into the affinity capillary by pressure and incubated for 1 h, and
then unbound sample was washed out of the column using PBS. The elution buffer (50
mM formic acid or glycine buffer, pH 2.4) was introduced into the affinity capillary and
incubated for 15 min to desorb hCG. Finally, pressure was used to drive eluted hCG
through the capillary for UV detection.
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5.2.7 CE of hCG
I used a Crytstal CE 300 system (ATI, Madison, WI) with 50 mM AF-FA as the
separation buffer for CE of hCG. UV-Vis absorbance detection at 214 nm was performed
using an online Crystal 100 variable wavelength UV-Vis absorbance detector. Data were
collected and analyzed using a ChromPerfect software workstation (Mountain View, CA).
Following the preconditioning of the capillary, a small plug of 0.2 mg/mL hCG was
injected into the capillary by pressure (1000 mbar) for 50 s, and 12 kV was used to
separate the hCG sample. For preconcentration/CE experiments, preconcentration was
performed as in the adsorption/desorption experiments in Section 5.2.6, and CE
conditions were the same as above. Briefly, the hCG sample was introduced into the
affinity capillary by pressure and incubated for 1 h, and then unbound sample was
washed out of the column using PBS. The elution buffer (50 mM glycine buffer, pH 2.4)
was introduced into the affinity capillary and incubated for 15 min to desorb adsorbed
protein. Finally, CE was used to drive eluted hCG through the capillary for UV detection.

5.3 Results and Disscussion
5.3.1 Attachment of Antibodies on Monolith Surfaces
After polymerization, the GMA-based monolith surfaces have pendant epoxy groups,
which are reactive under appropriate conditions [4]. As described in Section 1.3.3.1, these
epoxy groups can react directly with protein amino groups to form a covalent linkage, but
the reaction is slow, requires high protein concentrations, and cannot control the antibody
orientation. Thus, I used a variant of Pierce protocols (see Section 1.3.3.5) [5] to attach
oriented antibodies to GMA monoliths (Figure 5.1). In this method, an antibody is
partially reduced to give reactive sulfhydryl groups at the end of the heavy chains, and
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the sulfhydryls react with the monolith surface for covalent attachment. Since attachment
only occurs through the heavy chains, the light chains are still free, which is
advantageous, since in most cases the active sites of an antibody are on the light chains
[6].
5.3.2 Blocking Nonspecific Adsorption on Monoliths
The epoxy groups of a native GMA monolith are prone to nonspecific protein adsorption,
which could interfere with the antibody-antigen interaction. Also, the chemical treatments
used to attach antibodies on the monolith (Figure 5.1) could provide adsorption sites.
Thus, I used dynamic BSA coating to block nonspecific adsorption on native GMAEDMA monoliths. After treatment with 1% BSA solution in PBS, myoglobin, GFP and
trypsin did not adsorb to the monolith surface. Figure 5.2 shows fluorescence images of
myoglobin adsorption on untreated and BSA-blocked GMA-EDMA monoliths.
Nonspecific adsorption was not observed on BSA-blocked monoliths, while severe
adsorption was found on untreated GMA-EDMA. Importantly, no detectable BSA bleed
was found during CE experiments on these columns. These results indicate that BSA
blocking might provide a good strategy to eliminate nonspecific protein adsorption in
GMA monoliths.
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(a)

(b)

Figure 5.2 Fluorescence micrographs of adsorbed FITC-myoglobin in (a) untreated
and (b) BSA-blocked GMA-EDMA monoliths. Dashed lines define the capillaries.
Another possible solution to nonspecific adsorption is to change the monolith recipe. As
discussed in Chapters 3 and 4, a poly(ethylene glycol) (PEG) coating on a polymer
surface can reduce nonspecific protein adsorption. Thus, I prepared a monolith that had
PEGDA instead of EDMA as the crosslinking agent. FITC-BSA was used to test protein
adsorption on GMA-PEGDA and GMA-EDMA monoliths, as described in Section 5.2.5.
After 2 h Tris buffer washing, I observed severe protein adsorption on GMA-EDMA
surfaces (Figure 5.3a), but no protein adsorption on the GMA-PEGDA surface (Figure
5.3c). After 12 h washing with acetic acid/acetate buffer (pH 4.4), most (~90%) of the
FITC-BSA that had been adsorbed to the GMA-EDMA monolith was removed (Figure
5.3b). These results show that the GMA-PEGDA monolith should have better
performance in dealing with nonspecific adsorption.
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Figure 5.3 Fluorescence micrographs of adsorbed FITC-BSA on (a, b) GMA-EDMA
and (c) GMA-PEGDA monoliths; (a) and (c) were taken after 2 h Tris buffer
washing, while (b) was taken after 12 h acetate buffer washing.
5.3.3 Adsorption-Desorption Tests of hCG
To test the application of my monolith-based affinity columns in cancer marker detection,
I used hCG as a model protein. As discussed in Section 1.3.1.2, hCG is important in
cancer detection, and several variants exist in serum. Here, I tested preconcentration and
CE of hCG and free βhCG on a GMA-EDMA-based affinity column. An
adsorption/desorption test was used to determine optimum operation conditions for hCG
preconcentration.
5.3.3.1 Incubation
I first determined the optimal incubation time for hCG/antibody interaction by testing
times from 5-90 min. Longer incubation times gave greater hCG adsorption, but if the
incubation time was too long, the column was not usable for affinity CE. Ultimately, I
found 1 h to be the best incubation time.
5.3.3.2 Elution
The elution buffer is also critical for affinity interaction. To probe the elution, I designed
a test using FITC-labeled hCG, as described in Section 5.2.6. The best elution condition
was 15 min with glycine buffer. Although longer elution times could provide more
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complete hCG removal, prolonged exposure of the monolith to acidic solution could
cause damage to the affinity column. Figure 5.4 shows the elution of hCG from an
affinity column. The adsorption/desorption tests were reproducible, as similar detector
traces were found in 4 replicate experiments.

Figure 5.4 Elution of hCG from an affinity column.

5.3.4 CE of hCG
I carried out CE of hCG and βhCG in fused silica capillaries. The initial results indicate
that βhCG and hCG have different mobilities (Figure 5.5). CE analysis of both hCG and
βhCG was complete within 40 min, and the migration times for these two analytes
differed by about 3 min, which indicates that CE could be used to separate hCG and
βhCG after preconcentration.
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Figure 5.5 CE of (a) hCG and (b) βhCG. The narrow spikes in (b) are due to bubbles
or instrumental instabilities.
5.3.5 Preconcentration and CE of hCG
Figure 5.6 shows CE of desorbed hCG after it was selectively enriched on a GMAEDMA affinity column. Preconcentration and elution buffer incubation were carried out
before the start of the electropherogram. This result indicates that my affinity column had
the ability to selectively enrich hCG from a sample solution and separate it using CE.
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Elution Buffer

Figure 5.6 Preconcentration and CE of hCG in an affinity column.

5.4 Conclusion
A method (adapted from Pierce’s published protocols) was developed to attach oriented
antibodies on monoliths. To reduce nonspecific adsorption, BSA solution was used to
block the monolith surface. Selective preconcentration and elution of hCG has been
performed in these affinity columns, which indicates promise for application in cancer
marker detection. Future work will involve preconcentration and CE separation of a
mixture that contains both βhCG and hCG.
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Chapter 6 Conclusions and Future Directions
6.1 Conclusions
6.1.1 Fabrication of CaF2 Capillary Electrophoresis Microdevices for on-chip IR
Detection
In Chapter 2, I describe the fabrication and testing of microfluidic capillary
electrophoresis (CE) devices made of CaF2. These microchips open the door to optical
detection in the ultraviolet, visible, and infrared spectral regions. I performed CE of
fluorescently labeled amino acids in CaF2 microdevices. Although the CE results in
Chapter 2 are not optimal, they still indicate that CaF2 microfluidic systems can provide a
suitable platform for rapid biochemical separations. I also performed IR spectroscopy for
qualitative analyte identification in CaF2 microchannels, which was the first
demonstration of on-chip IR detection in a µTAS device. My results show that CaF2
microfluidic devices are suitable for online FT-IR identification of analytes in the
channels. These CaF2 microchips should enable both quantitative and qualitative optical
analysis in lab-on-a-chip systems.
6.1.2 Surface Modification of Polymeric Microdevices
Chapters 3 and 4 show surface modification of polymer microdevices for bioanalytical
applications. Two polymers, poly(methyl methacrylate) (PMMA, Chapter 3) and
thermoset polyester (TPE, Chapter 4), were studied in this research. My results should
further the application of polymer microdevices in biomolecular analysis.
In Chapter 3, microchip CE of proteins and protein digests was evaluated in PMMA
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microdevices. To improve separation efficiency and reduce protein adsorption, two
methods, dynamic coating and poly(ethylene glycol) (PEG) grafting using atom transfer
radical polymerization (ATRP), were used for the surface modification of PMMA
microdevices. Theoretical plate counts as high as 2.2 × 104 were achieved for protein
separations in PEG-grafted PMMA microdevices. The relative standard deviation of
migration time for BSA separations in PEG-modified PMMA microchips was 1.3% over
10 runs. My work indicates that ATRP grafting of PEG offers superior results to dynamic
coating in PMMA microchip performance in protein separations. Moreover, my
experiments show that PMMA microfluidic systems should be well suited for highperformance separations needed to characterize complex biological mixtures.
To apply surface modification more broadly in polymer microdevices, I developed inchannel ATRP and applied this approach in the surface derivatization of TPE
microdevices with PEG. In-channel ATRP is performed after device bonding, so it is
useful in polymer microchips that cannot be surface modified before enclosure. Moreover,
my work showed that ATRP can be carried out in close-to-still (non-flowing) conditions,
which had not been demonstrated previously. I have characterized PEG-grafted TPE
microdevices with X-ray photoelectron spectroscopy, electroosmotic flow (EOF), and
contact angle measurements. The results indicate that a thin PEG layer has been grafted
in the TPE channels. Moreover, reduced nonspecific adsorption and lower, more pHstable EOF was observed in PEG-grafted TPE microchannels. Amino acid and peptide
mixtures were separated in PEG-modified TPE chips with good efficiency and
reproducibility. CE of phosducin-like protein and phosphorylated phosducin-like protein
was also done to measure the phosphorylation efficiency. Analysis of these mixtures
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demonstrates the utility of surface-modified TPE microchips for the separation of
complex biological samples.
6.1.3 Affinity Techniques for Cancer Marker Analysis
In Chapter 5, I show the development of a new affinity column−CE system for cancer
marker analysis. I developed a method (adapted from Pierce’s published protocols) to
covalently attach appropriately oriented antibodies of interest on monolith surfaces such
that antibody activity can be retained. This technique could also be applied to attach other
proteins on monoliths, which could be useful in on-chip enzyme assays or protein
digestion. Moreover, I developed an approach to reduce nonspecific protein adsorption on
monoliths using bovine serum albumin (BSA). Selective preconcentration and elution of
human chorionic gonadotropin (hCG) have been performed using these affinity columns,
indicating promise for application in cancer marker detection. Importantly, my affinity
techniques could be coupled with other analytical instruments to improve their
performance.

6.2 Future Directions
6.2.1 CaF2 CE Microdevices
6.2.1.1 Fabrication of CaF2 Microdevices
In Chapter 2, I described the fabrication of CaF2 CE microchips and their application in
amino acid separation. However, the fabrication procedures need optimization. First, the
etching speed for FeNH4(SO4)2 is slow (less than 20 µm/day). Thus, new etchants are
needed for making high-aspect-ratio CaF2 microfeatures. Second, a new bonding method
needs to be developed. In Chapter 2, I utilized photoresist as an adhesive to bond CaF2

137

pieces together; this introduces some problems, such as non-uniform channel properties,
EOF, nonspecific adsorption, etc. It would be valuable to develop a method to directly
bond two CaF2 substrates together. I propose that CaF2 substrates can be bonded together
at high temperature under an inert atmosphere. From my initial work on direct bonding,
900 °C should be sufficient to seal CaF2 pieces together, but an inert atmosphere or
vacuum is required, because trace water vapor in air can degrade CaF2.
Figure 6.1 shows a proposed new scheme for CaF2 microchannel fabrication. Briefly,
after a CaF2 substrate is cleaned with acetone (Figure 6.1a), a sacrificial layer that defines
microdevice channel features is patterned photolithographically on the CaF2 surface
(Figure 6.1b). The sacrificial layer could be photoresist (e.g., SU-8), silicon dioxide,
Si3N4, or a metal. Then, e-beam [1] or thermal evaporation [2] could be used to deposit a
thin layer of CaF2 on the patterned substrate (Figure 6.1c). Finally, the sacrificial layer
could be etched, leaving channel features (Figure 6.1d), and high-temperature direct
bonding will be used to enclose the microchannels. Compared to the approach in Chapter
2, this new method would provide more uniform surface properties for the bonded CaF2
channels and greater device bond strength.
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Figure 6.1 Fabrication of CaF2 microdevices using sacrificial methods.

6.2.1.2 Separation and Detection in CaF2 Microdevices

One unique feature of CaF2 microdevices is that almost no EOF is present, which makes
high-performance CE possible. Chapter 2 showed that amino acids could be separated in
CaF2 microdevices. In the future, it would be valuable to use these systems in the
separation of peptides, proteins or nucleic acids. To achieve this goal, longer separation
channels will be required and new fabrication methods, such as sacrificial techniques,
thermal bonding, etc., will need to be developed.
In Chapter 2, I gave initial IR detection results in CaF2 microchannels; however, on-chip
IR detection of separations was not done. Thus, in the future, I propose to perform onchip IR detection of protein or nucleic acid separations in CaF2 microchannels. IR should
be useful as a universal detection method for biomolecular analysis in CaF2 microdevices.
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6.2.2 Surface Modification of Polymeric Microdevices

6.2.2.1 ATRP Surface Modification

In Chapters 3-4 I showed that ATRP surface modification was an effective method to
improve biomolecular analysis performance in polymeric microdevices. After ATRP,
lower and pH-stable EOF, as well as reduced protein adsorption, were observed in PEGgrafted PMMA and TPE microchannels. The CE performance for PEG-grafted polymer
microdevices was also improved. I propose that ATRP surface modification could be
applied to other polymer microdevices to improve their biomolecular analysis
performance. Moreover, new approaches need to be developed to graft other proteinresistant materials on polymer surfaces using ATRP.

6.2.2.2 New Bioanalytical Applications for Polymeric Microdevices

My research showed improved protein, peptide and amino acid separations in polymeric
microdevices. Besides these biomolecules, nucleic acids, fatty acids, and hormones are
other important species for separation. Since PEG grafting can reduce EOF and
nonspecific adsorption, I am confident that such polymer microdevices should have broad
potential in analysis of other biomolecules.
In Chapters 3 and 4, I only performed CE analyses in my polymer microdevices; however,
there are many other analytical techniques that could be incorporated into polymer
microchips. For example, affinity methods are important in biochemistry and medicine,
because of selective and strong interaction toward targets. With the surface modification
methods that I developed in Chapters 3 and 4, it should be possible to introduce affinity
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columns into polymer microdevices. To achieve this goal, I propose to use anchor
molecules (e.g., PEG-aldehyde derivatives, which can be obtained from Sigma) that can
react with proteins or nucleotides and be grafted on surfaces through ATRP. Affinitymodified polymer microchips should be advantageous relative to the more costly and
difficult to fabricate glass devices.
6.2.3 Affinity Techniques for Cancer Marker Analysis
6.2.3.1 New Methods to Attach Antibodies on Monoliths
Besides the methods discussed in Chapters 1 and 5, improved approaches should be
developed to provide active and oriented antibodies attached to polymer surfaces. I
propose an alternative method to attach antibodies on a monolith, based on DNA
hybridization. This technique will include three steps: (1) attachment of oligonucleotides
to the monolith, (2) linking of antibodies to nucleic acids, and (3) hybridization.
The first step is the attachment of oligonucleotides to monoliths. Methods have been
developed to affix oligonucleotides to glass surfaces [3], and I will modify these
approaches to attach oligonucleotides to monoliths. As shown in Figure 6.2a, epoxy
groups can be reacted with ethylenediamine (EDA), leaving a pendant amine group. Two
options are available to link oligonucleotides to amines. The first possibility is to link the
oligonucletide 5’-phosphate group directly to surface amines under the catalysis of Nethyl-N′-(3-dimethylaminopropyl) carbodiimide (EDC) imidazole (Figure 6.2b). The
second option needs thiol-modified oligonucleotides [4-6]; sulfo-SMCC reacts with the
monolith surface amine groups, and this is followed by attachment of thiol-labeled
oligonucleotides

(Figure

6.2c).

Besides

sulfo-SMCC,

m-maleimidobenzoyl-N-
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hydroxysulfosuccinimide
sulfosuccinimidyl

ester;

N-[g-maleimidobutyryloxy]sulfosuccinimide

4-[p-maleimidophenyl]butyrate,

or

ester;

N-sulfosuccinimidyl[4-

iodoacetyl]aminobenzoate could also be used as the crosslinking agent [3].

Figure 6.2 Antibody attachment to GMA monoliths using hybridization. Part 1:
attaching oligonucleotides.
The second step is to attach the antibody to an oligonucleotide that is the perfect
complement to the surface-affixed one. Two methods will be explored for this purpose.
One option is to react partially reduced antibodies with thiol-labeled oligonucleotides
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(Figure 6.3a). The other possibility is to use crosslinkers to attach antibodies to thiollabeled oligonucleotides. For example, as shown in Figure 6.3b, sulfo-SMCC can link to
antibodies through an antibody primary amine. Then the other side of SMCC can form a
bond with a thiol-labeled oligonucleotide. The first of these methods is most promising,
because the orientation of attached antibodies can be controlled best.

Figure 6.3 Antibody attachment to GMA monoliths using hybridization. Part 2:
linking oligonucleotides to antibodies.
Once the first two steps are finished, the oligonucleotide-attached antibody solution will
be flushed through the DNA-modified monolith, and specific hybridization will affix
antibodies to the surface. This base-pairing attachment is strong, and normally only high
temperature (>90 °C) or solvent can break it. Moreover, DNA denaturation can be used to
detach antibodies from the monolith to allow changing or reconfiguration as desired.
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6.2.3.2 Surface Modification to Eliminate Nonspecific Adsorption

As I have observed in Chapter 5.3.2, native GMA monoliths are prone to protein
adsorption. I have tested hCG, β-casein, trypsin and green fluorescent protein, and all of
them have some nonspecific adsorption on native GMA monoliths. Also, the attachment
of antibodies on GMA monoliths includes three steps: amine group linkage, sulfo-SMCC
reaction and antibody fragment attachment. Each step may introduce potential adsorption
sites on the monolith surface. Some nonspecifically adsorbed proteins may be attaching
to the monolith through the epoxy groups; these proteins are so strongly adsorbed that
even acidic solution (pH 2.5) cannot elute them effectively. Some proteins are also
adsorbed weakly on the monolith; these molecules may be eluted and washed out with
the target protein, thus interfering with affinity experiments. One method used to
eliminate nonspecific adsorption is to react the monolith with Tris, aspartic acid or
hydrogen peroxide to remove residual active epoxy groups [7]. Although these reactions
deactivate the epoxy groups, they introduce new functionalities on the monolith, which
could also lead to nonspecific adsorption. One solution to nonspecific protein adsorption
is to use a protein like bovine serum albumin (BSA) to block adsorption sites, as reported
in Chapter 5. However, BSA blocking has several disadvantages: 1) it may interfere with
the antibody/antigen interaction, 2) BSA bleeding from the monolith over time may
increase nonspecific adsorption, and 3) BSA that bleeds from the monolith may co-elute
with the target protein. Thus, new methods should be developed to solve the nonspecific
adsorption problem.
In Chapters 3 and 4, I have attached PEG chains on polymer surfaces to reduce
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nonspecific adsorption [8]. After PEG grafting, most proteins, including BSA and βcasein, do not adsorb. I propose that PEG could be used to block nonspecific adsorption
on monoliths; however, there are two groups on the monolith that could cause
nonspecific adsorption: unreacted epoxy groups and amine groups (unreacted sulfoSMCC will be hydrolyzed so it should not cause problems). To block residual epoxy
groups, I propose to flush a PEG derivative through the monolith (Figure 6.4a). To block
unreacted amine groups, PEG aldehydes will be passed through the column (Figure 6.4b).
Both these PEG derivatives can be purchased from Sigma. These surface blocking steps
must be done after antibody attachment. Importantly, since the reaction between the PEGaldehyde and antibody amine groups requires high antibody concentration (2 mg/mL) and
long reaction time (4 h) [9], attachment of PEG to antibody amines should be limited.
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Figure 6.4 PEG grafting on GMA monoliths to reduce nonspecific adsorption. (a)
Blocking epoxy groups with a PEG derivative and (b) blocking surface amine
groups with a PEG-aldehyde reagent.
An alternative surface modification method for epoxy deactivation is PEG grafting using
ATRP [10, 11] after EDA treatment of the monolith. ATRP [12-14] has been used for
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chemical derivatization of PDMS [15, 16] and PMMA [8] microchannels. Surface GMA
epoxy groups should react with the ATRP initiator under appropriate conditions, while the
surface amine groups will be inert. Subsequently, the chosen polymer can be grafted to
the surface, as shown in Figure 6.5. The grafted PEG layer should provide low and pHstable EOF. Moreover, ATRP attachment of PEG chains should eliminate reactive GMA
groups that could cause nonspecific adsorption. Last, the ATRP process has no
interference with the immobilized amine groups, so subsequent antibody immobilization
can be done.

Figure 6.5 Schematic of ATRP modification of a GMA monolith.
A third option for surface modification is to grow a thin PEG layer using photoinitiation
after antibody attachment. Photoinitiator-induced radical polymerization has been applied
widely for polymerization of acrylate or styrene-based formulations, and a broad variety
of radical photoinitiators have been developed, such as tetraalkylammonium salts,
titanocene, and 2,2-dimethoxy-2-phenylacetophenone (DMPA) for initiation with 300400 nm UV light [17]. The photo-induced polymerization includes two steps and would
be performed after antibody attachment. First, I will convert unreacted epoxy groups to
aldehydes by acid hydrolysis and NaIO4 oxidation. After that, I propose to fill the
monolith with PEG acrylate derivatives (monomers) and DMPA (initiator), and irradiate
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UV light for polymerization. One concern for this approach is that attached antibodies
could react with the surface aldehyde groups, which would reduce the performance of the
affinity column.
6.2.3.3 Affinity-coupled Electric Field Gradient Focusing (EFGF) of hCG
As an extension of my work in Chapter 5, I suggest the coupling of affinity columns with
EFGF devices, pursuing two approaches. The first method is to directly integrate an
antibody column into an EFGF device, as shown in Figure 6.6a. This method is similar to
my approach to connect an affinity column with CE in Chapter 5. After a capillary basedEFGF device is produced (as described in Section 1.4), an affinity column (1.5-2 cm long)
can be made at one end, which can be connected to a syringe pump for sample
introduction, preconcentration and elution. Then, EFGF can be used to separate and focus
eluted proteins. This integration method is relatively simple and eliminates the problem
of dead volume. However, a potential issue is that the integrated device will lose its
function if either of its components (affinity or EFGF) fails. In addition, the integration
will increase the device fabrication time and complexity.
The other solution is to utilize an injection valve to connect an affinity column to an
EFGF device (Figure 6.6b). The affinity column could be fabricated separately from the
EFGF device and connected through a valve. When protein preconcentration is
performed, the valve would be adjusted to flow sample through the affinity column to
sample waste, bypassing the EFGF device. After preconcentration is done, the valve
would be switched to connect the affinity column to the EFGF section so the
preconcentrated proteins could be eluted and transferred to the EFGF device for analysis.
Once the sample is loaded from the affinity column, the valve would be switched to
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connect the syringe pump (for EFGF flow control) to the EFGF device. Compared to the
first method, the device fabrication for this design should be much easier. Moreover, the
lifetime for this type of affinity-coupled EFGF device should be longer, because either
the affinity column or the EFGF device could be easily changed to perform new tasks or
replace non-functioning components. However, this method creates dead volume and
other possible complications due to the usage of valves and/or fittings.

Figure 6.6 Coupling of an affinity column to an EFGF device.
The eventual objective of affinity-coupled EFGF is to analyze biological samples (such
as blood or urine). In addition to proteins, real samples contain carbohydrates, fatty acids,
nucleic acids and other small molecules, which need to be removed prior to loading on
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the affinity column. I suggest that conventional protocols, which include centrifugation,
acetonitrile extraction, aqueous methanol extraction and lyophilization, could be used to
achieve this aim [18, 19]. For a real biological sample, IgG, albumin, hemoglobin and
other abundant proteins are another concern. Commercially available abundant protein
removal kits (e.g., Abundant Protein Removal Kit from Merck or ProteoSeek
Albumin/IgG Removal Kits from Pierce) can remove these proteins. After these
pretreatments, the sample can be introduced directly into the affinity column to extract
target proteins. Once concentrated, the markers can be transferred to the EFGF device for
focusing and separation.

6.2.3.4 Application of Affinity-Coupled EFGF to Cancer Marker Analysis

One of the advantages of antibody-coupled EFGF is that it should be able to enrich
proteins of interest from a complex biological sample (e.g., blood or urine) Affinitycoupled monolith columns have good potential for analysis of several cancer markers:
carcinoembryonic antigens, prostate-specific antigen, alpha-fetoprotein, cancer antigen
125, and cancer antigens 15-3 and 27.29. Antibodies to each type of marker need to be
attached to the monolith column. It will also be necessary to optimize the sample, elution,
and EFGF buffers, as well as voltage and flow parameters for EFGF. Each cancer marker
can be tested in affinity-coupled EFGF individually to find the optimal conditions. Finally,
multiple types of antibodies can be attached in one column to perform affinity
preconcentration and EFGF of multiple markers at the same time.
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6.3 Summary and Perspective
The ultimate aim of my research is to detect diseases at early stages using microdevices.
My work has focused on the fabrication and testing of micro total analysis systems
(µTAS) for bioanalytical applications. I developed microdevices made of CaF2 and tested
their application in CE separations and on-chip IR spectroscopy. I also worked on the
surface modification of polymeric microdevices and applied them in protein, peptide and
amino acid separations. Last, I developed a method for the attachment of appropriately
oriented antibodies on GMA monoliths, and applied this setup in hCG preconcentration
and separation. Importantly, there are many promising future directions for my work. My
research on the fabrication and surface modification of microdevices should benefit the
development of new µTAS applications, while my studies on protein, peptide, amino acid
and cancer marker separations should be useful for biomarker analysis. I am optimistic
that someday these techniques will be used clinically in routine analysis of real samples.
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